Project
Illumina Body Map 2: averaged replicates
Navigation
Downloads
Results for HMX3
Z-value: 1.69
Motif logo
Transcription factors associated with HMX3
| Gene Symbol | Gene ID | Gene Info |
|---|---|---|
|
HMX3
|
ENSG00000188620.9 | H6 family homeobox 3 |
Activity-expression correlation:
| Gene | Promoter | Pearson corr. coef. | P-value | Plot |
|---|---|---|---|---|
| HMX3 | hg19_v2_chr10_+_124895472_124895508 | 0.33 | 6.1e-02 | Click! |
Activity profile of HMX3 motif
Sorted Z-values of HMX3 motif
| Promoter | Log-likelihood | Transcript | Gene | Gene Info |
|---|---|---|---|---|
| chr5_+_140227048 | 3.90 |
ENST00000532602.1
|
PCDHA9
|
protocadherin alpha 9 |
| chr1_+_87012753 | 3.42 |
ENST00000370563.3
|
CLCA4
|
chloride channel accessory 4 |
| chr21_+_41239243 | 2.97 |
ENST00000328619.5
|
PCP4
|
Purkinje cell protein 4 |
| chr18_+_29171689 | 2.69 |
ENST00000237014.3
|
TTR
|
transthyretin |
| chr1_+_87012922 | 2.65 |
ENST00000263723.5
|
CLCA4
|
chloride channel accessory 4 |
| chr4_-_69817481 | 2.56 |
ENST00000251566.4
|
UGT2A3
|
UDP glucuronosyltransferase 2 family, polypeptide A3 |
| chr3_-_165555200 | 2.53 |
ENST00000479451.1
ENST00000540653.1 ENST00000488954.1 ENST00000264381.3 |
BCHE
|
butyrylcholinesterase |
| chr5_+_175288631 | 2.50 |
ENST00000509837.1
|
CPLX2
|
complexin 2 |
| chr8_-_86290333 | 2.37 |
ENST00000521846.1
ENST00000523022.1 ENST00000524324.1 ENST00000519991.1 ENST00000520663.1 ENST00000517590.1 ENST00000522579.1 ENST00000522814.1 ENST00000522662.1 ENST00000523858.1 ENST00000519129.1 |
CA1
|
carbonic anhydrase I |
| chr11_-_128894053 | 2.30 |
ENST00000392657.3
|
ARHGAP32
|
Rho GTPase activating protein 32 |
| chr5_+_17404147 | 2.29 |
ENST00000507730.1
|
RP11-321E2.3
|
RP11-321E2.3 |
| chr9_+_103947311 | 2.28 |
ENST00000395056.2
|
LPPR1
|
Lipid phosphate phosphatase-related protein type 1 |
| chr2_+_108994633 | 2.25 |
ENST00000409309.3
|
SULT1C4
|
sulfotransferase family, cytosolic, 1C, member 4 |
| chr6_-_52628271 | 2.15 |
ENST00000493422.1
|
GSTA2
|
glutathione S-transferase alpha 2 |
| chr8_-_112039621 | 2.11 |
ENST00000523557.1
|
RP11-946L20.2
|
RP11-946L20.2 |
| chr2_-_224467093 | 2.09 |
ENST00000305409.2
|
SCG2
|
secretogranin II |
| chr17_-_42992856 | 2.06 |
ENST00000588316.1
ENST00000435360.2 ENST00000586793.1 ENST00000588735.1 ENST00000588037.1 ENST00000592320.1 ENST00000253408.5 |
GFAP
|
glial fibrillary acidic protein |
| chr5_-_35938674 | 2.06 |
ENST00000397366.1
ENST00000513623.1 ENST00000514524.1 ENST00000397367.2 |
CAPSL
|
calcyphosine-like |
| chr14_+_24540046 | 2.06 |
ENST00000397016.2
ENST00000537691.1 ENST00000560356.1 ENST00000558450.1 |
CPNE6
|
copine VI (neuronal) |
| chr8_+_91803695 | 2.02 |
ENST00000417640.2
|
NECAB1
|
N-terminal EF-hand calcium binding protein 1 |
| chr5_-_142077569 | 1.98 |
ENST00000407758.1
ENST00000441680.2 ENST00000419524.2 |
FGF1
|
fibroblast growth factor 1 (acidic) |
| chr17_-_38821373 | 1.98 |
ENST00000394052.3
|
KRT222
|
keratin 222 |
| chr2_+_200472779 | 1.91 |
ENST00000427045.1
ENST00000419243.1 |
AC093590.1
|
AC093590.1 |
| chr4_-_88450244 | 1.91 |
ENST00000503414.1
|
SPARCL1
|
SPARC-like 1 (hevin) |
| chr4_-_185139062 | 1.91 |
ENST00000296741.2
|
ENPP6
|
ectonucleotide pyrophosphatase/phosphodiesterase 6 |
| chr2_+_102953608 | 1.90 |
ENST00000311734.2
ENST00000409584.1 |
IL1RL1
|
interleukin 1 receptor-like 1 |
| chr2_+_173686303 | 1.87 |
ENST00000397087.3
|
RAPGEF4
|
Rap guanine nucleotide exchange factor (GEF) 4 |
| chr4_-_122854612 | 1.85 |
ENST00000264811.5
|
TRPC3
|
transient receptor potential cation channel, subfamily C, member 3 |
| chr4_-_88449771 | 1.82 |
ENST00000535835.1
|
SPARCL1
|
SPARC-like 1 (hevin) |
| chr12_+_107078474 | 1.82 |
ENST00000552866.1
ENST00000229387.5 |
RFX4
|
regulatory factor X, 4 (influences HLA class II expression) |
| chr8_+_35649365 | 1.80 |
ENST00000437887.1
|
AC012215.1
|
Uncharacterized protein |
| chrX_+_38420623 | 1.78 |
ENST00000378482.2
|
TSPAN7
|
tetraspanin 7 |
| chr4_+_41258786 | 1.77 |
ENST00000503431.1
ENST00000284440.4 ENST00000508768.1 ENST00000512788.1 |
UCHL1
|
ubiquitin carboxyl-terminal esterase L1 (ubiquitin thiolesterase) |
| chr6_-_94129244 | 1.74 |
ENST00000369303.4
ENST00000369297.1 |
EPHA7
|
EPH receptor A7 |
| chr6_-_84419101 | 1.74 |
ENST00000520302.1
ENST00000520213.1 ENST00000439399.2 ENST00000428679.2 ENST00000437520.1 |
SNAP91
|
synaptosomal-associated protein, 91kDa |
| chr18_-_24765248 | 1.73 |
ENST00000580774.1
ENST00000284224.8 |
CHST9
|
carbohydrate (N-acetylgalactosamine 4-0) sulfotransferase 9 |
| chr13_-_47471155 | 1.68 |
ENST00000543956.1
ENST00000542664.1 |
HTR2A
|
5-hydroxytryptamine (serotonin) receptor 2A, G protein-coupled |
| chr7_-_107883678 | 1.65 |
ENST00000417701.1
|
NRCAM
|
neuronal cell adhesion molecule |
| chr4_-_88450372 | 1.65 |
ENST00000543631.1
|
SPARCL1
|
SPARC-like 1 (hevin) |
| chr2_+_155555201 | 1.65 |
ENST00000544049.1
|
KCNJ3
|
potassium inwardly-rectifying channel, subfamily J, member 3 |
| chr2_-_209054709 | 1.65 |
ENST00000449053.1
ENST00000451346.1 ENST00000341287.4 |
C2orf80
|
chromosome 2 open reading frame 80 |
| chrX_-_15511438 | 1.65 |
ENST00000380420.5
|
PIR
|
pirin (iron-binding nuclear protein) |
| chr2_+_27071045 | 1.63 |
ENST00000401478.1
|
DPYSL5
|
dihydropyrimidinase-like 5 |
| chr1_+_77333117 | 1.62 |
ENST00000477717.1
|
ST6GALNAC5
|
ST6 (alpha-N-acetyl-neuraminyl-2,3-beta-galactosyl-1,3)-N-acetylgalactosaminide alpha-2,6-sialyltransferase 5 |
| chr4_-_90759440 | 1.59 |
ENST00000336904.3
|
SNCA
|
synuclein, alpha (non A4 component of amyloid precursor) |
| chr2_-_224467002 | 1.58 |
ENST00000421386.1
ENST00000433889.1 |
SCG2
|
secretogranin II |
| chr15_+_54305101 | 1.57 |
ENST00000260323.11
ENST00000545554.1 ENST00000537900.1 |
UNC13C
|
unc-13 homolog C (C. elegans) |
| chr2_+_27071292 | 1.56 |
ENST00000431402.1
ENST00000434719.1 |
DPYSL5
|
dihydropyrimidinase-like 5 |
| chr19_-_3478477 | 1.55 |
ENST00000591708.1
|
C19orf77
|
chromosome 19 open reading frame 77 |
| chr18_+_50278430 | 1.54 |
ENST00000578080.1
ENST00000582875.1 ENST00000412726.1 |
DCC
|
deleted in colorectal carcinoma |
| chr3_-_187009646 | 1.52 |
ENST00000296280.6
ENST00000392470.2 ENST00000169293.6 ENST00000439271.1 ENST00000392472.2 ENST00000392475.2 |
MASP1
|
mannan-binding lectin serine peptidase 1 (C4/C2 activating component of Ra-reactive factor) |
| chr4_-_16675930 | 1.49 |
ENST00000503178.2
|
LDB2
|
LIM domain binding 2 |
| chr3_+_26735991 | 1.48 |
ENST00000456208.2
|
LRRC3B
|
leucine rich repeat containing 3B |
| chr7_+_97361218 | 1.48 |
ENST00000319273.5
|
TAC1
|
tachykinin, precursor 1 |
| chrX_+_38420783 | 1.48 |
ENST00000422612.2
ENST00000286824.6 ENST00000545599.1 |
TSPAN7
|
tetraspanin 7 |
| chr4_+_69962185 | 1.47 |
ENST00000305231.7
|
UGT2B7
|
UDP glucuronosyltransferase 2 family, polypeptide B7 |
| chr15_+_51669513 | 1.46 |
ENST00000558426.1
|
GLDN
|
gliomedin |
| chr1_+_99127225 | 1.44 |
ENST00000370189.5
ENST00000529992.1 |
SNX7
|
sorting nexin 7 |
| chr15_+_69857515 | 1.43 |
ENST00000559477.1
|
RP11-279F6.1
|
RP11-279F6.1 |
| chr1_+_197237352 | 1.42 |
ENST00000538660.1
ENST00000367400.3 ENST00000367399.2 |
CRB1
|
crumbs homolog 1 (Drosophila) |
| chr5_+_17404114 | 1.42 |
ENST00000508677.1
|
RP11-321E2.3
|
RP11-321E2.3 |
| chr9_+_27109392 | 1.39 |
ENST00000406359.4
|
TEK
|
TEK tyrosine kinase, endothelial |
| chr4_-_168155169 | 1.37 |
ENST00000534949.1
ENST00000535728.1 |
SPOCK3
|
sparc/osteonectin, cwcv and kazal-like domains proteoglycan (testican) 3 |
| chr2_+_27070964 | 1.37 |
ENST00000288699.6
|
DPYSL5
|
dihydropyrimidinase-like 5 |
| chr7_-_16921601 | 1.37 |
ENST00000402239.3
ENST00000310398.2 ENST00000414935.1 |
AGR3
|
anterior gradient 3 |
| chr6_-_52668605 | 1.36 |
ENST00000334575.5
|
GSTA1
|
glutathione S-transferase alpha 1 |
| chr6_+_29624758 | 1.35 |
ENST00000376917.3
ENST00000376902.3 ENST00000533330.2 ENST00000376888.2 |
MOG
|
myelin oligodendrocyte glycoprotein |
| chr6_-_169654139 | 1.35 |
ENST00000366787.3
|
THBS2
|
thrombospondin 2 |
| chr3_+_121613265 | 1.35 |
ENST00000295605.2
|
SLC15A2
|
solute carrier family 15 (oligopeptide transporter), member 2 |
| chr3_-_107099454 | 1.35 |
ENST00000593837.1
ENST00000599431.1 |
RP11-446H18.5
|
RP11-446H18.5 |
| chr2_+_234621551 | 1.33 |
ENST00000608381.1
ENST00000373414.3 |
UGT1A1
UGT1A5
|
UDP glucuronosyltransferase 1 family, polypeptide A8 UDP glucuronosyltransferase 1 family, polypeptide A5 |
| chr19_-_47975417 | 1.33 |
ENST00000236877.6
|
SLC8A2
|
solute carrier family 8 (sodium/calcium exchanger), member 2 |
| chr1_+_151693984 | 1.33 |
ENST00000479191.1
|
RIIAD1
|
regulatory subunit of type II PKA R-subunit (RIIa) domain containing 1 |
| chr8_+_101349823 | 1.33 |
ENST00000519566.1
|
KB-1991G8.1
|
KB-1991G8.1 |
| chr14_+_32798547 | 1.32 |
ENST00000557354.1
ENST00000557102.1 ENST00000557272.1 |
AKAP6
|
A kinase (PRKA) anchor protein 6 |
| chr16_-_20364030 | 1.32 |
ENST00000396134.2
ENST00000573567.1 ENST00000570757.1 ENST00000424589.1 ENST00000302509.4 ENST00000571174.1 ENST00000576688.1 |
UMOD
|
uromodulin |
| chr4_-_10686475 | 1.31 |
ENST00000226951.6
|
CLNK
|
cytokine-dependent hematopoietic cell linker |
| chr6_+_12290586 | 1.31 |
ENST00000379375.5
|
EDN1
|
endothelin 1 |
| chrX_-_43741594 | 1.30 |
ENST00000536181.1
ENST00000378069.4 |
MAOB
|
monoamine oxidase B |
| chrX_-_92928557 | 1.30 |
ENST00000373079.3
ENST00000475430.2 |
NAP1L3
|
nucleosome assembly protein 1-like 3 |
| chr18_-_61311485 | 1.30 |
ENST00000436264.1
ENST00000356424.6 ENST00000341074.5 |
SERPINB4
|
serpin peptidase inhibitor, clade B (ovalbumin), member 4 |
| chr18_-_24722995 | 1.30 |
ENST00000581714.1
|
CHST9
|
carbohydrate (N-acetylgalactosamine 4-0) sulfotransferase 9 |
| chr10_-_7513904 | 1.29 |
ENST00000420395.1
|
RP5-1031D4.2
|
RP5-1031D4.2 |
| chr10_-_61900762 | 1.29 |
ENST00000355288.2
|
ANK3
|
ankyrin 3, node of Ranvier (ankyrin G) |
| chr15_+_73976545 | 1.27 |
ENST00000318443.5
ENST00000537340.2 ENST00000318424.5 |
CD276
|
CD276 molecule |
| chr15_-_56757329 | 1.26 |
ENST00000260453.3
|
MNS1
|
meiosis-specific nuclear structural 1 |
| chr1_-_110933611 | 1.25 |
ENST00000472422.2
ENST00000437429.2 |
SLC16A4
|
solute carrier family 16, member 4 |
| chr4_-_46126093 | 1.24 |
ENST00000295452.4
|
GABRG1
|
gamma-aminobutyric acid (GABA) A receptor, gamma 1 |
| chr16_-_19897455 | 1.23 |
ENST00000568214.1
ENST00000569479.1 |
GPRC5B
|
G protein-coupled receptor, family C, group 5, member B |
| chr1_+_201979645 | 1.22 |
ENST00000367284.5
ENST00000367283.3 |
ELF3
|
E74-like factor 3 (ets domain transcription factor, epithelial-specific ) |
| chr6_-_46293378 | 1.22 |
ENST00000330430.6
|
RCAN2
|
regulator of calcineurin 2 |
| chr6_+_73076432 | 1.22 |
ENST00000414192.2
|
RIMS1
|
regulating synaptic membrane exocytosis 1 |
| chr7_+_29603394 | 1.22 |
ENST00000319694.2
|
PRR15
|
proline rich 15 |
| chr5_-_11588907 | 1.21 |
ENST00000513598.1
ENST00000503622.1 |
CTNND2
|
catenin (cadherin-associated protein), delta 2 |
| chr1_+_156308403 | 1.20 |
ENST00000481479.1
ENST00000368252.1 ENST00000466306.1 ENST00000368251.1 |
TSACC
|
TSSK6 activating co-chaperone |
| chr18_+_43304137 | 1.19 |
ENST00000502059.2
ENST00000586951.1 ENST00000589322.2 ENST00000415427.3 ENST00000535474.1 ENST00000402943.2 |
SLC14A1
|
solute carrier family 14 (urea transporter), member 1 (Kidd blood group) |
| chr4_+_69962212 | 1.19 |
ENST00000508661.1
|
UGT2B7
|
UDP glucuronosyltransferase 2 family, polypeptide B7 |
| chr4_+_75174180 | 1.19 |
ENST00000413830.1
|
EPGN
|
epithelial mitogen |
| chr1_+_15250596 | 1.18 |
ENST00000361144.5
|
KAZN
|
kazrin, periplakin interacting protein |
| chr8_-_13134045 | 1.18 |
ENST00000512044.2
|
DLC1
|
deleted in liver cancer 1 |
| chr10_-_124459284 | 1.18 |
ENST00000432000.1
ENST00000329446.4 |
C10orf120
|
chromosome 10 open reading frame 120 |
| chr8_-_112039643 | 1.18 |
ENST00000524283.1
|
RP11-946L20.2
|
RP11-946L20.2 |
| chr4_-_90756769 | 1.17 |
ENST00000345009.4
ENST00000505199.1 ENST00000502987.1 |
SNCA
|
synuclein, alpha (non A4 component of amyloid precursor) |
| chr2_+_166095898 | 1.17 |
ENST00000424833.1
ENST00000375437.2 ENST00000357398.3 |
SCN2A
|
sodium channel, voltage-gated, type II, alpha subunit |
| chr15_-_30261066 | 1.17 |
ENST00000558447.1
|
TJP1
|
tight junction protein 1 |
| chr14_-_37642016 | 1.17 |
ENST00000331299.5
|
SLC25A21
|
solute carrier family 25 (mitochondrial oxoadipate carrier), member 21 |
| chr9_+_6215799 | 1.16 |
ENST00000417746.2
ENST00000456383.2 |
IL33
|
interleukin 33 |
| chr12_-_15374343 | 1.16 |
ENST00000256953.2
ENST00000546331.1 |
RERG
|
RAS-like, estrogen-regulated, growth inhibitor |
| chr6_+_88757507 | 1.15 |
ENST00000237201.1
|
SPACA1
|
sperm acrosome associated 1 |
| chr15_+_101417919 | 1.15 |
ENST00000561338.1
|
ALDH1A3
|
aldehyde dehydrogenase 1 family, member A3 |
| chrX_+_17755696 | 1.14 |
ENST00000419185.1
|
SCML1
|
sex comb on midleg-like 1 (Drosophila) |
| chr18_-_24443151 | 1.14 |
ENST00000440832.3
|
AQP4
|
aquaporin 4 |
| chr15_-_78913521 | 1.14 |
ENST00000326828.5
|
CHRNA3
|
cholinergic receptor, nicotinic, alpha 3 (neuronal) |
| chr6_-_26027480 | 1.14 |
ENST00000377364.3
|
HIST1H4B
|
histone cluster 1, H4b |
| chr19_-_51192661 | 1.14 |
ENST00000391813.1
|
SHANK1
|
SH3 and multiple ankyrin repeat domains 1 |
| chr4_-_177116772 | 1.14 |
ENST00000280191.2
|
SPATA4
|
spermatogenesis associated 4 |
| chr1_-_72566613 | 1.13 |
ENST00000306821.3
|
NEGR1
|
neuronal growth regulator 1 |
| chr19_+_54466179 | 1.13 |
ENST00000270458.2
|
CACNG8
|
calcium channel, voltage-dependent, gamma subunit 8 |
| chr19_-_41985048 | 1.12 |
ENST00000599801.1
ENST00000595063.1 ENST00000598215.1 |
AC011526.1
|
AC011526.1 |
| chr8_+_67405794 | 1.12 |
ENST00000522977.1
ENST00000480005.1 |
C8orf46
|
chromosome 8 open reading frame 46 |
| chr6_+_25652432 | 1.12 |
ENST00000377961.2
|
SCGN
|
secretagogin, EF-hand calcium binding protein |
| chr5_-_102898465 | 1.10 |
ENST00000507423.1
ENST00000230792.2 |
NUDT12
|
nudix (nucleoside diphosphate linked moiety X)-type motif 12 |
| chr15_-_78913628 | 1.10 |
ENST00000348639.3
|
CHRNA3
|
cholinergic receptor, nicotinic, alpha 3 (neuronal) |
| chr10_+_18240814 | 1.10 |
ENST00000377374.4
|
SLC39A12
|
solute carrier family 39 (zinc transporter), member 12 |
| chr5_-_9630463 | 1.09 |
ENST00000382492.2
|
TAS2R1
|
taste receptor, type 2, member 1 |
| chr16_-_20364122 | 1.09 |
ENST00000396138.4
ENST00000577168.1 |
UMOD
|
uromodulin |
| chr12_-_123450986 | 1.09 |
ENST00000344275.7
ENST00000442833.2 ENST00000280560.8 ENST00000540285.1 ENST00000346530.5 |
ABCB9
|
ATP-binding cassette, sub-family B (MDR/TAP), member 9 |
| chr1_-_67266939 | 1.08 |
ENST00000304526.2
|
INSL5
|
insulin-like 5 |
| chr7_+_95401877 | 1.08 |
ENST00000524053.1
ENST00000324972.6 ENST00000537881.1 ENST00000437599.1 ENST00000359388.4 ENST00000413338.1 |
DYNC1I1
|
dynein, cytoplasmic 1, intermediate chain 1 |
| chr11_+_64685026 | 1.07 |
ENST00000526559.1
|
PPP2R5B
|
protein phosphatase 2, regulatory subunit B', beta |
| chr5_+_140588269 | 1.07 |
ENST00000541609.1
ENST00000239450.2 |
PCDHB12
|
protocadherin beta 12 |
| chr6_+_26204825 | 1.07 |
ENST00000360441.4
|
HIST1H4E
|
histone cluster 1, H4e |
| chr3_+_159557637 | 1.06 |
ENST00000445224.2
|
SCHIP1
|
schwannomin interacting protein 1 |
| chr3_-_98235962 | 1.06 |
ENST00000513873.1
|
CLDND1
|
claudin domain containing 1 |
| chr1_-_111174054 | 1.05 |
ENST00000369770.3
|
KCNA2
|
potassium voltage-gated channel, shaker-related subfamily, member 2 |
| chr3_+_75955817 | 1.05 |
ENST00000487694.3
ENST00000602589.1 |
ROBO2
|
roundabout, axon guidance receptor, homolog 2 (Drosophila) |
| chrX_+_36053908 | 1.05 |
ENST00000378660.2
|
CHDC2
|
calponin homology domain containing 2 |
| chr5_+_140220769 | 1.05 |
ENST00000531613.1
ENST00000378123.3 |
PCDHA8
|
protocadherin alpha 8 |
| chr14_+_24540154 | 1.05 |
ENST00000559778.1
ENST00000560761.1 ENST00000557889.1 |
CPNE6
|
copine VI (neuronal) |
| chr22_-_30814469 | 1.05 |
ENST00000598426.1
|
KIAA1658
|
KIAA1658 |
| chr6_+_112408768 | 1.04 |
ENST00000368656.2
ENST00000604268.1 |
FAM229B
|
family with sequence similarity 229, member B |
| chr6_+_29624898 | 1.03 |
ENST00000396704.3
ENST00000483013.1 ENST00000490427.1 ENST00000416766.2 ENST00000376891.4 ENST00000376898.3 ENST00000396701.2 ENST00000494692.1 ENST00000431798.2 |
MOG
|
myelin oligodendrocyte glycoprotein |
| chr14_-_47812321 | 1.03 |
ENST00000357362.3
ENST00000486952.2 ENST00000426342.1 |
MDGA2
|
MAM domain containing glycosylphosphatidylinositol anchor 2 |
| chr2_+_108994466 | 1.03 |
ENST00000272452.2
|
SULT1C4
|
sulfotransferase family, cytosolic, 1C, member 4 |
| chr11_-_7698453 | 1.02 |
ENST00000524608.1
|
CYB5R2
|
cytochrome b5 reductase 2 |
| chr5_-_142065612 | 1.02 |
ENST00000360966.5
ENST00000411960.1 |
FGF1
|
fibroblast growth factor 1 (acidic) |
| chr12_+_26164645 | 1.02 |
ENST00000542004.1
|
RASSF8
|
Ras association (RalGDS/AF-6) domain family (N-terminal) member 8 |
| chr13_-_49987885 | 1.02 |
ENST00000409082.1
|
CAB39L
|
calcium binding protein 39-like |
| chr1_-_211307404 | 1.02 |
ENST00000367007.4
|
KCNH1
|
potassium voltage-gated channel, subfamily H (eag-related), member 1 |
| chr18_+_68002675 | 1.02 |
ENST00000584919.1
|
RP11-41O4.1
|
Uncharacterized protein |
| chr19_-_51531210 | 1.01 |
ENST00000391804.3
|
KLK11
|
kallikrein-related peptidase 11 |
| chr14_-_80697396 | 1.00 |
ENST00000557010.1
|
DIO2
|
deiodinase, iodothyronine, type II |
| chr8_-_30706608 | 1.00 |
ENST00000256246.2
|
TEX15
|
testis expressed 15 |
| chr21_-_22175341 | 1.00 |
ENST00000416768.1
ENST00000452561.1 ENST00000419299.1 ENST00000437238.1 |
LINC00320
|
long intergenic non-protein coding RNA 320 |
| chr17_-_55911970 | 0.99 |
ENST00000581805.1
ENST00000580960.1 |
RP11-60A24.3
|
RP11-60A24.3 |
| chrX_+_71996972 | 0.99 |
ENST00000334036.5
|
DMRTC1B
|
DMRT-like family C1B |
| chr3_+_38537960 | 0.99 |
ENST00000453767.1
|
EXOG
|
endo/exonuclease (5'-3'), endonuclease G-like |
| chr21_+_44073916 | 0.98 |
ENST00000349112.3
ENST00000398224.3 |
PDE9A
|
phosphodiesterase 9A |
| chr2_-_134326009 | 0.98 |
ENST00000409261.1
ENST00000409213.1 |
NCKAP5
|
NCK-associated protein 5 |
| chr5_+_140201183 | 0.96 |
ENST00000529619.1
ENST00000529859.1 ENST00000378126.3 |
PCDHA5
|
protocadherin alpha 5 |
| chr11_+_62104897 | 0.96 |
ENST00000415229.2
ENST00000535727.1 ENST00000301776.5 |
ASRGL1
|
asparaginase like 1 |
| chr17_-_29624343 | 0.95 |
ENST00000247271.4
|
OMG
|
oligodendrocyte myelin glycoprotein |
| chr5_+_175490540 | 0.95 |
ENST00000515817.1
|
FAM153B
|
family with sequence similarity 153, member B |
| chr8_-_124749609 | 0.95 |
ENST00000262219.6
ENST00000419625.1 |
ANXA13
|
annexin A13 |
| chr11_-_101000445 | 0.95 |
ENST00000534013.1
|
PGR
|
progesterone receptor |
| chr19_-_51531272 | 0.94 |
ENST00000319720.7
|
KLK11
|
kallikrein-related peptidase 11 |
| chr15_+_35838396 | 0.94 |
ENST00000501169.2
|
DPH6-AS1
|
DPH6 antisense RNA 1 (head to head) |
| chr5_+_150404904 | 0.93 |
ENST00000521632.1
|
GPX3
|
glutathione peroxidase 3 (plasma) |
| chr7_+_151653464 | 0.93 |
ENST00000431418.2
ENST00000392800.2 |
GALNTL5
|
UDP-N-acetyl-alpha-D-galactosamine:polypeptide N-acetylgalactosaminyltransferase-like 5 |
| chr5_+_146614579 | 0.93 |
ENST00000541094.1
ENST00000398521.3 |
STK32A
|
serine/threonine kinase 32A |
| chr9_+_71357171 | 0.93 |
ENST00000440050.1
|
PIP5K1B
|
phosphatidylinositol-4-phosphate 5-kinase, type I, beta |
| chr14_+_60386853 | 0.91 |
ENST00000570145.1
|
LRRC9
|
leucine rich repeat containing 9 |
| chr8_+_95565947 | 0.91 |
ENST00000523011.1
|
RP11-267M23.4
|
RP11-267M23.4 |
| chr7_+_147830776 | 0.91 |
ENST00000538075.1
|
CNTNAP2
|
contactin associated protein-like 2 |
| chr6_+_72922590 | 0.91 |
ENST00000523963.1
|
RIMS1
|
regulating synaptic membrane exocytosis 1 |
| chr9_+_27109440 | 0.90 |
ENST00000519080.1
|
TEK
|
TEK tyrosine kinase, endothelial |
| chr2_+_108863651 | 0.90 |
ENST00000329106.2
ENST00000376700.1 |
SULT1C3
|
sulfotransferase family, cytosolic, 1C, member 3 |
| chr8_+_39442097 | 0.90 |
ENST00000265707.5
ENST00000379866.1 ENST00000520772.1 ENST00000541111.1 |
ADAM18
|
ADAM metallopeptidase domain 18 |
| chr6_-_135271219 | 0.90 |
ENST00000367847.2
ENST00000367845.2 |
ALDH8A1
|
aldehyde dehydrogenase 8 family, member A1 |
| chr18_+_10526008 | 0.90 |
ENST00000542979.1
ENST00000322897.6 |
NAPG
|
N-ethylmaleimide-sensitive factor attachment protein, gamma |
| chr14_+_32798462 | 0.89 |
ENST00000280979.4
|
AKAP6
|
A kinase (PRKA) anchor protein 6 |
| chr15_-_99791413 | 0.89 |
ENST00000394129.2
ENST00000558663.1 ENST00000394135.3 ENST00000561365.1 ENST00000560279.1 |
TTC23
|
tetratricopeptide repeat domain 23 |
| chr14_-_105420241 | 0.89 |
ENST00000557457.1
|
AHNAK2
|
AHNAK nucleoprotein 2 |
| chr5_-_74162605 | 0.88 |
ENST00000389156.4
ENST00000510496.1 ENST00000380515.3 |
FAM169A
|
family with sequence similarity 169, member A |
| chr6_+_151561085 | 0.88 |
ENST00000402676.2
|
AKAP12
|
A kinase (PRKA) anchor protein 12 |
| chr2_+_149974684 | 0.88 |
ENST00000450639.1
|
LYPD6B
|
LY6/PLAUR domain containing 6B |
| chr3_-_151034734 | 0.88 |
ENST00000260843.4
|
GPR87
|
G protein-coupled receptor 87 |
| chr21_+_44073860 | 0.87 |
ENST00000335512.4
ENST00000539837.1 ENST00000291539.6 ENST00000380328.2 ENST00000398232.3 ENST00000398234.3 ENST00000398236.3 ENST00000328862.6 ENST00000335440.6 ENST00000398225.3 ENST00000398229.3 ENST00000398227.3 |
PDE9A
|
phosphodiesterase 9A |
| chr8_+_67405755 | 0.87 |
ENST00000521495.1
|
C8orf46
|
chromosome 8 open reading frame 46 |
| chr9_-_104198042 | 0.86 |
ENST00000374855.4
|
ALDOB
|
aldolase B, fructose-bisphosphate |
| chr7_+_54398390 | 0.86 |
ENST00000458615.1
ENST00000426205.1 |
RP11-436F9.1
|
RP11-436F9.1 |
| chr1_+_160097462 | 0.86 |
ENST00000447527.1
|
ATP1A2
|
ATPase, Na+/K+ transporting, alpha 2 polypeptide |
| chr5_+_140557371 | 0.86 |
ENST00000239444.2
|
PCDHB8
|
protocadherin beta 8 |
| chr4_+_139230865 | 0.85 |
ENST00000502757.1
ENST00000507145.1 ENST00000515282.1 ENST00000510736.1 |
LINC00499
|
long intergenic non-protein coding RNA 499 |
| chr18_+_5748793 | 0.85 |
ENST00000566533.1
ENST00000562452.2 |
RP11-945C19.1
|
RP11-945C19.1 |
| chr21_-_34185944 | 0.85 |
ENST00000479548.1
|
C21orf62
|
chromosome 21 open reading frame 62 |
| chr7_-_107968921 | 0.85 |
ENST00000442580.1
|
NRCAM
|
neuronal cell adhesion molecule |
| chr10_+_18689637 | 0.84 |
ENST00000377315.4
|
CACNB2
|
calcium channel, voltage-dependent, beta 2 subunit |
| chr20_+_123010 | 0.84 |
ENST00000382398.3
|
DEFB126
|
defensin, beta 126 |
| chr10_+_18240753 | 0.84 |
ENST00000377369.2
|
SLC39A12
|
solute carrier family 39 (zinc transporter), member 12 |
Network of associatons between targets according to the STRING database.
First level regulatory network of HMX3
Gene Ontology Analysis
Gene overrepresentation in biological_process category:
| Log-likelihood per target | Total log-likelihood | Term | Description |
|---|---|---|---|
| 0.7 | 3.5 | GO:1903285 | negative regulation of dopamine uptake involved in synaptic transmission(GO:0051585) norepinephrine uptake(GO:0051620) regulation of norepinephrine uptake(GO:0051621) negative regulation of norepinephrine uptake(GO:0051622) negative regulation of catecholamine uptake involved in synaptic transmission(GO:0051945) regulation of glutathione peroxidase activity(GO:1903282) positive regulation of glutathione peroxidase activity(GO:1903284) positive regulation of hydrogen peroxide catabolic process(GO:1903285) positive regulation of peroxidase activity(GO:2000470) |
| 0.6 | 1.9 | GO:0014016 | neuroblast differentiation(GO:0014016) |
| 0.6 | 1.8 | GO:0007412 | axon target recognition(GO:0007412) |
| 0.6 | 1.7 | GO:0018969 | thiocyanate metabolic process(GO:0018969) |
| 0.6 | 2.2 | GO:0060084 | synaptic transmission involved in micturition(GO:0060084) |
| 0.5 | 1.5 | GO:2000854 | positive regulation of corticosterone secretion(GO:2000854) |
| 0.5 | 2.4 | GO:0072023 | thick ascending limb development(GO:0072023) metanephric thick ascending limb development(GO:0072233) |
| 0.4 | 1.3 | GO:0042270 | protection from natural killer cell mediated cytotoxicity(GO:0042270) |
| 0.4 | 1.5 | GO:0021965 | spinal cord ventral commissure morphogenesis(GO:0021965) |
| 0.4 | 1.1 | GO:0060166 | olfactory pit development(GO:0060166) |
| 0.4 | 1.1 | GO:0050894 | determination of affect(GO:0050894) |
| 0.4 | 1.1 | GO:0006742 | NADP catabolic process(GO:0006742) pyridine nucleotide catabolic process(GO:0019364) |
| 0.4 | 2.8 | GO:0048014 | Tie signaling pathway(GO:0048014) |
| 0.3 | 1.7 | GO:0010513 | positive regulation of phosphatidylinositol biosynthetic process(GO:0010513) |
| 0.3 | 1.3 | GO:0060585 | nitric oxide transport(GO:0030185) negative regulation of nitric-oxide synthase biosynthetic process(GO:0051771) regulation of prostaglandin-endoperoxide synthase activity(GO:0060584) positive regulation of prostaglandin-endoperoxide synthase activity(GO:0060585) |
| 0.3 | 7.9 | GO:0052695 | cellular glucuronidation(GO:0052695) |
| 0.3 | 1.9 | GO:0050925 | negative regulation of negative chemotaxis(GO:0050925) |
| 0.3 | 0.9 | GO:0071109 | superior temporal gyrus development(GO:0071109) |
| 0.3 | 1.2 | GO:1901350 | cell-cell signaling involved in cell-cell junction organization(GO:1901350) |
| 0.3 | 0.9 | GO:1903280 | negative regulation of calcium:sodium antiporter activity(GO:1903280) |
| 0.3 | 2.2 | GO:1902261 | positive regulation of delayed rectifier potassium channel activity(GO:1902261) |
| 0.3 | 1.9 | GO:0038172 | interleukin-33-mediated signaling pathway(GO:0038172) |
| 0.3 | 3.7 | GO:0035766 | cell chemotaxis to fibroblast growth factor(GO:0035766) endothelial cell chemotaxis to fibroblast growth factor(GO:0035768) regulation of cell chemotaxis to fibroblast growth factor(GO:1904847) regulation of endothelial cell chemotaxis to fibroblast growth factor(GO:2000544) |
| 0.3 | 1.6 | GO:0072658 | maintenance of protein location in membrane(GO:0072658) maintenance of protein location in plasma membrane(GO:0072660) positive regulation of membrane depolarization during cardiac muscle cell action potential(GO:1900827) |
| 0.3 | 1.5 | GO:0006726 | eye pigment biosynthetic process(GO:0006726) eye pigment metabolic process(GO:0042441) pigment metabolic process involved in developmental pigmentation(GO:0043324) pigment metabolic process involved in pigmentation(GO:0043474) |
| 0.2 | 0.7 | GO:0019287 | isopentenyl diphosphate biosynthetic process, mevalonate pathway(GO:0019287) |
| 0.2 | 1.9 | GO:0071918 | urea transmembrane transport(GO:0071918) |
| 0.2 | 0.9 | GO:0060748 | tertiary branching involved in mammary gland duct morphogenesis(GO:0060748) |
| 0.2 | 0.7 | GO:0060304 | regulation of phosphatidylinositol dephosphorylation(GO:0060304) |
| 0.2 | 1.9 | GO:0010615 | positive regulation of cardiac muscle adaptation(GO:0010615) positive regulation of cardiac muscle hypertrophy in response to stress(GO:1903244) |
| 0.2 | 0.7 | GO:0070563 | negative regulation of vitamin D receptor signaling pathway(GO:0070563) |
| 0.2 | 4.6 | GO:0045162 | clustering of voltage-gated sodium channels(GO:0045162) |
| 0.2 | 3.9 | GO:0048245 | eosinophil chemotaxis(GO:0048245) |
| 0.2 | 1.8 | GO:0051480 | regulation of cytosolic calcium ion concentration(GO:0051480) |
| 0.2 | 2.9 | GO:0051388 | positive regulation of neurotrophin TRK receptor signaling pathway(GO:0051388) |
| 0.2 | 2.2 | GO:0031914 | negative regulation of synaptic plasticity(GO:0031914) |
| 0.2 | 1.3 | GO:0045915 | positive regulation of catecholamine metabolic process(GO:0045915) positive regulation of dopamine metabolic process(GO:0045964) |
| 0.2 | 1.1 | GO:2000253 | positive regulation of feeding behavior(GO:2000253) |
| 0.2 | 0.6 | GO:0006424 | glutamyl-tRNA aminoacylation(GO:0006424) |
| 0.2 | 0.8 | GO:0000711 | meiotic DNA repair synthesis(GO:0000711) |
| 0.2 | 0.4 | GO:0032304 | negative regulation of icosanoid secretion(GO:0032304) |
| 0.2 | 1.2 | GO:0009449 | gamma-aminobutyric acid biosynthetic process(GO:0009449) |
| 0.2 | 1.0 | GO:0034334 | adherens junction maintenance(GO:0034334) |
| 0.2 | 2.4 | GO:0006857 | oligopeptide transport(GO:0006857) |
| 0.2 | 0.8 | GO:0006208 | pyrimidine nucleobase catabolic process(GO:0006208) thymine catabolic process(GO:0006210) thymine metabolic process(GO:0019859) |
| 0.2 | 0.6 | GO:0034059 | response to anoxia(GO:0034059) |
| 0.2 | 0.8 | GO:0098942 | cytoskeletal matrix organization at active zone(GO:0048789) neurexin clustering involved in presynaptic membrane assembly(GO:0097115) retrograde trans-synaptic signaling by trans-synaptic protein complex(GO:0098942) |
| 0.2 | 2.7 | GO:0070327 | thyroid hormone transport(GO:0070327) |
| 0.2 | 0.9 | GO:2000721 | positive regulation of transcription from RNA polymerase II promoter involved in smooth muscle cell differentiation(GO:2000721) |
| 0.2 | 0.7 | GO:0018963 | insecticide metabolic process(GO:0017143) phthalate metabolic process(GO:0018963) |
| 0.2 | 0.7 | GO:0033504 | floor plate development(GO:0033504) |
| 0.2 | 0.5 | GO:2000687 | negative regulation of rubidium ion transport(GO:2000681) negative regulation of rubidium ion transmembrane transporter activity(GO:2000687) |
| 0.2 | 1.1 | GO:0021633 | optic nerve structural organization(GO:0021633) |
| 0.2 | 1.7 | GO:0010459 | negative regulation of heart rate(GO:0010459) |
| 0.2 | 1.2 | GO:0015742 | alpha-ketoglutarate transport(GO:0015742) |
| 0.2 | 3.6 | GO:0098828 | positive regulation of inhibitory postsynaptic potential(GO:0097151) modulation of inhibitory postsynaptic potential(GO:0098828) |
| 0.2 | 1.8 | GO:0021914 | negative regulation of smoothened signaling pathway involved in ventral spinal cord patterning(GO:0021914) |
| 0.2 | 0.5 | GO:0060488 | orthogonal dichotomous subdivision of terminal units involved in lung branching morphogenesis(GO:0060488) planar dichotomous subdivision of terminal units involved in lung branching morphogenesis(GO:0060489) lateral sprouting involved in lung morphogenesis(GO:0060490) |
| 0.2 | 0.3 | GO:2000177 | regulation of neural precursor cell proliferation(GO:2000177) |
| 0.2 | 0.6 | GO:1900111 | positive regulation of histone H3-K9 dimethylation(GO:1900111) |
| 0.2 | 0.9 | GO:0061760 | antifungal innate immune response(GO:0061760) |
| 0.1 | 0.4 | GO:1902173 | negative regulation of keratinocyte apoptotic process(GO:1902173) |
| 0.1 | 1.9 | GO:0019695 | choline metabolic process(GO:0019695) |
| 0.1 | 1.2 | GO:0051025 | negative regulation of immunoglobulin secretion(GO:0051025) |
| 0.1 | 1.7 | GO:0030951 | establishment or maintenance of microtubule cytoskeleton polarity(GO:0030951) |
| 0.1 | 2.3 | GO:0001867 | complement activation, lectin pathway(GO:0001867) |
| 0.1 | 1.4 | GO:0042904 | 9-cis-retinoic acid biosynthetic process(GO:0042904) 9-cis-retinoic acid metabolic process(GO:0042905) |
| 0.1 | 1.6 | GO:0098914 | membrane repolarization during atrial cardiac muscle cell action potential(GO:0098914) |
| 0.1 | 0.7 | GO:0046726 | positive regulation by virus of viral protein levels in host cell(GO:0046726) |
| 0.1 | 0.9 | GO:0006982 | response to lipid hydroperoxide(GO:0006982) |
| 0.1 | 1.1 | GO:0072275 | metanephric glomerulus morphogenesis(GO:0072275) metanephric glomerulus vasculature morphogenesis(GO:0072276) metanephric glomerular capillary formation(GO:0072277) |
| 0.1 | 0.4 | GO:0006532 | aspartate biosynthetic process(GO:0006532) |
| 0.1 | 0.4 | GO:0031247 | actin rod assembly(GO:0031247) |
| 0.1 | 2.1 | GO:1904714 | regulation of chaperone-mediated autophagy(GO:1904714) |
| 0.1 | 0.6 | GO:2000768 | glomerular parietal epithelial cell differentiation(GO:0072139) positive regulation of nephron tubule epithelial cell differentiation(GO:2000768) |
| 0.1 | 0.4 | GO:1904017 | cellular response to Thyroglobulin triiodothyronine(GO:1904017) |
| 0.1 | 0.7 | GO:0006001 | fructose catabolic process(GO:0006001) fructose catabolic process to hydroxyacetone phosphate and glyceraldehyde-3-phosphate(GO:0061624) |
| 0.1 | 0.6 | GO:0045065 | cytotoxic T cell differentiation(GO:0045065) |
| 0.1 | 0.6 | GO:0048867 | ganglion mother cell fate determination(GO:0007402) stem cell fate determination(GO:0048867) |
| 0.1 | 2.0 | GO:0046951 | ketone body biosynthetic process(GO:0046951) |
| 0.1 | 2.7 | GO:0019800 | peptide cross-linking via chondroitin 4-sulfate glycosaminoglycan(GO:0019800) |
| 0.1 | 0.3 | GO:0000454 | snoRNA guided rRNA pseudouridine synthesis(GO:0000454) |
| 0.1 | 0.7 | GO:0046373 | arabinose metabolic process(GO:0019566) L-arabinose metabolic process(GO:0046373) |
| 0.1 | 0.8 | GO:1904879 | positive regulation of calcium ion transmembrane transport via high voltage-gated calcium channel(GO:1904879) |
| 0.1 | 0.4 | GO:0090293 | nitrogen catabolite regulation of transcription from RNA polymerase II promoter(GO:0001079) nitrogen catabolite activation of transcription from RNA polymerase II promoter(GO:0001080) regulation of urea metabolic process(GO:0034255) intracellular bile acid receptor signaling pathway(GO:0038185) interleukin-17 secretion(GO:0072615) nitrogen catabolite regulation of transcription(GO:0090293) nitrogen catabolite activation of transcription(GO:0090294) regulation of nitrogen cycle metabolic process(GO:1903314) positive regulation of glutamate metabolic process(GO:2000213) regulation of ammonia assimilation cycle(GO:2001248) positive regulation of ammonia assimilation cycle(GO:2001250) |
| 0.1 | 3.7 | GO:1901687 | glutathione derivative metabolic process(GO:1901685) glutathione derivative biosynthetic process(GO:1901687) |
| 0.1 | 1.0 | GO:0000160 | phosphorelay signal transduction system(GO:0000160) |
| 0.1 | 0.8 | GO:2001023 | regulation of response to drug(GO:2001023) |
| 0.1 | 0.5 | GO:0015891 | iron chelate transport(GO:0015688) siderophore transport(GO:0015891) |
| 0.1 | 1.9 | GO:0051964 | negative regulation of synapse assembly(GO:0051964) |
| 0.1 | 0.1 | GO:0051389 | inactivation of MAPKK activity(GO:0051389) |
| 0.1 | 2.1 | GO:1900119 | positive regulation of execution phase of apoptosis(GO:1900119) |
| 0.1 | 0.7 | GO:1903899 | lung goblet cell differentiation(GO:0060480) positive regulation of PERK-mediated unfolded protein response(GO:1903899) |
| 0.1 | 0.3 | GO:0080120 | CAAX-box protein processing(GO:0071586) CAAX-box protein maturation(GO:0080120) |
| 0.1 | 0.3 | GO:0003050 | regulation of systemic arterial blood pressure by atrial natriuretic peptide(GO:0003050) |
| 0.1 | 1.2 | GO:0060087 | relaxation of vascular smooth muscle(GO:0060087) |
| 0.1 | 1.1 | GO:2000576 | positive regulation of microtubule motor activity(GO:2000576) regulation of ATP-dependent microtubule motor activity, plus-end-directed(GO:2000580) positive regulation of ATP-dependent microtubule motor activity, plus-end-directed(GO:2000582) |
| 0.1 | 2.5 | GO:0031915 | positive regulation of synaptic plasticity(GO:0031915) |
| 0.1 | 0.5 | GO:0093001 | glycolysis from storage polysaccharide through glucose-1-phosphate(GO:0093001) |
| 0.1 | 1.0 | GO:0006528 | asparagine metabolic process(GO:0006528) |
| 0.1 | 1.7 | GO:0046069 | cGMP catabolic process(GO:0046069) |
| 0.1 | 3.4 | GO:0001580 | detection of chemical stimulus involved in sensory perception of bitter taste(GO:0001580) |
| 0.1 | 0.5 | GO:0033512 | L-lysine catabolic process to acetyl-CoA via saccharopine(GO:0033512) |
| 0.1 | 0.1 | GO:1903371 | regulation of endoplasmic reticulum tubular network organization(GO:1903371) |
| 0.1 | 0.3 | GO:2001303 | response to interleukin-13(GO:0035962) cellular response to interleukin-13(GO:0035963) lipoxin biosynthetic process(GO:2001301) lipoxin A4 metabolic process(GO:2001302) lipoxin A4 biosynthetic process(GO:2001303) |
| 0.1 | 3.1 | GO:1903861 | positive regulation of dendrite extension(GO:1903861) |
| 0.1 | 0.6 | GO:0044026 | DNA hypermethylation(GO:0044026) |
| 0.1 | 1.6 | GO:0045741 | positive regulation of epidermal growth factor-activated receptor activity(GO:0045741) |
| 0.1 | 0.6 | GO:0007341 | penetration of zona pellucida(GO:0007341) |
| 0.1 | 0.2 | GO:0005989 | lactose metabolic process(GO:0005988) lactose biosynthetic process(GO:0005989) |
| 0.1 | 0.2 | GO:0042746 | regulation of circadian sleep/wake cycle, wakefulness(GO:0010840) circadian sleep/wake cycle, wakefulness(GO:0042746) |
| 0.1 | 0.7 | GO:0003383 | apical constriction(GO:0003383) |
| 0.1 | 1.2 | GO:0060056 | mammary gland involution(GO:0060056) |
| 0.1 | 0.9 | GO:0006776 | vitamin A metabolic process(GO:0006776) |
| 0.1 | 0.7 | GO:0010265 | SCF complex assembly(GO:0010265) |
| 0.1 | 0.2 | GO:0048162 | preantral ovarian follicle growth(GO:0001546) multi-layer follicle stage(GO:0048162) |
| 0.1 | 1.3 | GO:0048172 | regulation of short-term neuronal synaptic plasticity(GO:0048172) |
| 0.1 | 1.7 | GO:0071578 | zinc II ion transmembrane import(GO:0071578) |
| 0.1 | 1.0 | GO:0006682 | galactosylceramide biosynthetic process(GO:0006682) galactolipid biosynthetic process(GO:0019375) |
| 0.1 | 1.2 | GO:0008627 | intrinsic apoptotic signaling pathway in response to osmotic stress(GO:0008627) |
| 0.1 | 0.6 | GO:1902498 | regulation of protein autoubiquitination(GO:1902498) |
| 0.1 | 1.2 | GO:0016998 | cell wall macromolecule catabolic process(GO:0016998) |
| 0.1 | 0.5 | GO:1903575 | cornified envelope assembly(GO:1903575) |
| 0.1 | 1.6 | GO:0009312 | oligosaccharide biosynthetic process(GO:0009312) |
| 0.1 | 0.2 | GO:0006481 | C-terminal protein methylation(GO:0006481) |
| 0.1 | 0.3 | GO:0018312 | peptidyl-serine ADP-ribosylation(GO:0018312) |
| 0.1 | 0.3 | GO:0010902 | positive regulation of very-low-density lipoprotein particle remodeling(GO:0010902) positive regulation of phospholipid catabolic process(GO:0060697) |
| 0.1 | 0.5 | GO:0046208 | spermine catabolic process(GO:0046208) |
| 0.1 | 1.3 | GO:0070986 | left/right axis specification(GO:0070986) |
| 0.1 | 1.2 | GO:0045793 | positive regulation of cell size(GO:0045793) |
| 0.1 | 0.3 | GO:0060133 | somatotropin secreting cell development(GO:0060133) |
| 0.1 | 0.4 | GO:0046601 | positive regulation of centriole replication(GO:0046601) |
| 0.1 | 2.6 | GO:0030206 | chondroitin sulfate biosynthetic process(GO:0030206) |
| 0.1 | 1.6 | GO:0038063 | collagen-activated tyrosine kinase receptor signaling pathway(GO:0038063) |
| 0.1 | 0.2 | GO:0032053 | ciliary basal body organization(GO:0032053) |
| 0.1 | 0.1 | GO:0010002 | cardioblast differentiation(GO:0010002) |
| 0.1 | 0.3 | GO:0014005 | microglia differentiation(GO:0014004) microglia development(GO:0014005) axon midline choice point recognition(GO:0016199) cellular response to norepinephrine stimulus(GO:0071874) |
| 0.1 | 0.2 | GO:0061394 | regulation of transcription from RNA polymerase II promoter in response to arsenic-containing substance(GO:0061394) |
| 0.1 | 1.0 | GO:0001514 | selenocysteine incorporation(GO:0001514) translational readthrough(GO:0006451) |
| 0.1 | 0.2 | GO:0019442 | tryptophan catabolic process to acetyl-CoA(GO:0019442) |
| 0.1 | 0.9 | GO:0033033 | negative regulation of myeloid cell apoptotic process(GO:0033033) |
| 0.1 | 4.4 | GO:0015701 | bicarbonate transport(GO:0015701) |
| 0.1 | 0.6 | GO:0072513 | positive regulation of secondary heart field cardioblast proliferation(GO:0072513) |
| 0.1 | 0.4 | GO:0031098 | stress-activated protein kinase signaling cascade(GO:0031098) |
| 0.1 | 0.2 | GO:0002439 | chronic inflammatory response to antigenic stimulus(GO:0002439) |
| 0.1 | 0.3 | GO:0035407 | histone H3-T11 phosphorylation(GO:0035407) |
| 0.1 | 0.4 | GO:1904694 | negative regulation of vascular smooth muscle contraction(GO:1904694) |
| 0.1 | 0.2 | GO:0061300 | cerebellum vasculature development(GO:0061300) |
| 0.1 | 0.3 | GO:0032218 | riboflavin transport(GO:0032218) |
| 0.0 | 0.1 | GO:1902683 | regulation of receptor localization to synapse(GO:1902683) |
| 0.0 | 1.1 | GO:2000311 | regulation of alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionate selective glutamate receptor activity(GO:2000311) |
| 0.0 | 0.1 | GO:0000294 | nuclear-transcribed mRNA catabolic process, endonucleolytic cleavage-dependent decay(GO:0000294) |
| 0.0 | 0.4 | GO:0072092 | ureteric bud invasion(GO:0072092) metanephric renal vesicle formation(GO:0072093) |
| 0.0 | 0.3 | GO:0036343 | psychomotor behavior(GO:0036343) motor behavior(GO:0061744) |
| 0.0 | 0.6 | GO:0045078 | positive regulation of interferon-gamma biosynthetic process(GO:0045078) |
| 0.0 | 0.7 | GO:0048863 | stem cell differentiation(GO:0048863) |
| 0.0 | 7.2 | GO:1902476 | chloride transmembrane transport(GO:1902476) |
| 0.0 | 0.3 | GO:0052199 | negative regulation of catalytic activity in other organism involved in symbiotic interaction(GO:0052199) |
| 0.0 | 0.1 | GO:0060459 | left lung development(GO:0060459) positive regulation of mesenchymal cell proliferation involved in ureter development(GO:2000729) |
| 0.0 | 0.6 | GO:1904352 | positive regulation of protein catabolic process in the vacuole(GO:1904352) |
| 0.0 | 0.1 | GO:0006427 | histidyl-tRNA aminoacylation(GO:0006427) |
| 0.0 | 0.5 | GO:0019509 | L-methionine biosynthetic process from methylthioadenosine(GO:0019509) |
| 0.0 | 0.3 | GO:0003199 | endocardial cushion to mesenchymal transition involved in heart valve formation(GO:0003199) |
| 0.0 | 0.4 | GO:0002175 | protein localization to paranode region of axon(GO:0002175) |
| 0.0 | 0.2 | GO:0045875 | negative regulation of sister chromatid cohesion(GO:0045875) |
| 0.0 | 1.1 | GO:0006833 | water transport(GO:0006833) |
| 0.0 | 0.2 | GO:0006781 | succinyl-CoA pathway(GO:0006781) |
| 0.0 | 0.4 | GO:0051026 | chiasma assembly(GO:0051026) |
| 0.0 | 0.5 | GO:0060536 | cartilage morphogenesis(GO:0060536) |
| 0.0 | 0.2 | GO:1901529 | positive regulation of anion channel activity(GO:1901529) |
| 0.0 | 0.5 | GO:0070234 | positive regulation of T cell apoptotic process(GO:0070234) |
| 0.0 | 0.2 | GO:0009822 | alkaloid catabolic process(GO:0009822) |
| 0.0 | 1.7 | GO:0048268 | clathrin coat assembly(GO:0048268) |
| 0.0 | 1.5 | GO:0010669 | epithelial structure maintenance(GO:0010669) |
| 0.0 | 0.5 | GO:0030948 | negative regulation of vascular endothelial growth factor receptor signaling pathway(GO:0030948) |
| 0.0 | 0.3 | GO:0061141 | lung ciliated cell differentiation(GO:0061141) negative regulation of epithelial cell proliferation involved in lung morphogenesis(GO:2000795) |
| 0.0 | 0.3 | GO:0010025 | wax biosynthetic process(GO:0010025) wax metabolic process(GO:0010166) |
| 0.0 | 0.1 | GO:0050893 | sensory processing(GO:0050893) |
| 0.0 | 0.5 | GO:0003310 | pancreatic A cell differentiation(GO:0003310) |
| 0.0 | 0.1 | GO:0097198 | histone H3-K36 trimethylation(GO:0097198) |
| 0.0 | 0.4 | GO:0009249 | protein lipoylation(GO:0009249) |
| 0.0 | 0.5 | GO:0035860 | glial cell-derived neurotrophic factor receptor signaling pathway(GO:0035860) |
| 0.0 | 0.6 | GO:0021554 | optic nerve development(GO:0021554) |
| 0.0 | 0.2 | GO:0032231 | regulation of actin filament bundle assembly(GO:0032231) |
| 0.0 | 0.2 | GO:0061737 | leukotriene signaling pathway(GO:0061737) |
| 0.0 | 7.7 | GO:0007156 | homophilic cell adhesion via plasma membrane adhesion molecules(GO:0007156) |
| 0.0 | 0.1 | GO:0018874 | benzoate metabolic process(GO:0018874) |
| 0.0 | 0.5 | GO:0060242 | contact inhibition(GO:0060242) |
| 0.0 | 0.1 | GO:2000809 | positive regulation of synaptic vesicle clustering(GO:2000809) |
| 0.0 | 0.5 | GO:0071285 | cellular response to lithium ion(GO:0071285) |
| 0.0 | 1.1 | GO:0051923 | sulfation(GO:0051923) |
| 0.0 | 0.4 | GO:2000811 | negative regulation of anoikis(GO:2000811) |
| 0.0 | 0.3 | GO:0033184 | positive regulation of histone ubiquitination(GO:0033184) regulation of histone H2B ubiquitination(GO:2001166) positive regulation of histone H2B ubiquitination(GO:2001168) |
| 0.0 | 0.1 | GO:0010430 | fatty acid omega-oxidation(GO:0010430) |
| 0.0 | 0.6 | GO:0000338 | protein deneddylation(GO:0000338) |
| 0.0 | 1.0 | GO:0010569 | regulation of double-strand break repair via homologous recombination(GO:0010569) |
| 0.0 | 0.3 | GO:0090267 | positive regulation of mitotic cell cycle spindle assembly checkpoint(GO:0090267) |
| 0.0 | 0.4 | GO:0035721 | intraciliary retrograde transport(GO:0035721) |
| 0.0 | 0.7 | GO:0033141 | positive regulation of peptidyl-serine phosphorylation of STAT protein(GO:0033141) |
| 0.0 | 0.4 | GO:0018095 | protein polyglutamylation(GO:0018095) |
| 0.0 | 0.2 | GO:1903361 | protein localization to basolateral plasma membrane(GO:1903361) |
| 0.0 | 0.3 | GO:0007168 | receptor guanylyl cyclase signaling pathway(GO:0007168) |
| 0.0 | 0.1 | GO:0098905 | regulation of bundle of His cell action potential(GO:0098905) |
| 0.0 | 0.2 | GO:0032148 | activation of protein kinase B activity(GO:0032148) |
| 0.0 | 1.4 | GO:0007205 | protein kinase C-activating G-protein coupled receptor signaling pathway(GO:0007205) |
| 0.0 | 0.4 | GO:2001222 | regulation of neuron migration(GO:2001222) |
| 0.0 | 0.2 | GO:0006432 | phenylalanyl-tRNA aminoacylation(GO:0006432) |
| 0.0 | 1.0 | GO:0021522 | spinal cord motor neuron differentiation(GO:0021522) |
| 0.0 | 0.5 | GO:0018298 | protein-chromophore linkage(GO:0018298) |
| 0.0 | 0.8 | GO:0060285 | cilium-dependent cell motility(GO:0060285) |
| 0.0 | 0.9 | GO:0099601 | regulation of neurotransmitter receptor activity(GO:0099601) |
| 0.0 | 0.2 | GO:0019626 | short-chain fatty acid catabolic process(GO:0019626) |
| 0.0 | 0.7 | GO:0048934 | peripheral nervous system neuron differentiation(GO:0048934) peripheral nervous system neuron development(GO:0048935) |
| 0.0 | 0.9 | GO:0090036 | regulation of protein kinase C signaling(GO:0090036) |
| 0.0 | 0.4 | GO:0017121 | phospholipid scrambling(GO:0017121) |
| 0.0 | 0.5 | GO:0009308 | amine metabolic process(GO:0009308) |
| 0.0 | 0.1 | GO:0042769 | DNA damage response, detection of DNA damage(GO:0042769) |
| 0.0 | 0.2 | GO:0043473 | pigmentation(GO:0043473) |
| 0.0 | 2.6 | GO:0016266 | O-glycan processing(GO:0016266) |
| 0.0 | 0.2 | GO:0030242 | pexophagy(GO:0030242) |
| 0.0 | 0.5 | GO:0098719 | sodium ion import across plasma membrane(GO:0098719) sodium ion import into cell(GO:1990118) |
| 0.0 | 0.6 | GO:0043517 | positive regulation of DNA damage response, signal transduction by p53 class mediator(GO:0043517) |
| 0.0 | 0.1 | GO:0051754 | meiotic sister chromatid cohesion, centromeric(GO:0051754) |
| 0.0 | 0.5 | GO:1902083 | negative regulation of peptidyl-cysteine S-nitrosylation(GO:1902083) |
| 0.0 | 0.5 | GO:0033617 | mitochondrial respiratory chain complex IV assembly(GO:0033617) mitochondrial respiratory chain complex IV biogenesis(GO:0097034) |
| 0.0 | 1.1 | GO:0007339 | binding of sperm to zona pellucida(GO:0007339) |
| 0.0 | 0.1 | GO:0046391 | 5-phosphoribose 1-diphosphate biosynthetic process(GO:0006015) 5-phosphoribose 1-diphosphate metabolic process(GO:0046391) |
| 0.0 | 0.1 | GO:0009099 | branched-chain amino acid biosynthetic process(GO:0009082) leucine biosynthetic process(GO:0009098) valine biosynthetic process(GO:0009099) |
| 0.0 | 1.2 | GO:0035235 | ionotropic glutamate receptor signaling pathway(GO:0035235) |
| 0.0 | 0.1 | GO:0007089 | traversing start control point of mitotic cell cycle(GO:0007089) |
| 0.0 | 0.1 | GO:1900226 | negative regulation of NLRP3 inflammasome complex assembly(GO:1900226) |
| 0.0 | 0.1 | GO:0008218 | bioluminescence(GO:0008218) |
| 0.0 | 0.2 | GO:0015846 | polyamine transport(GO:0015846) |
| 0.0 | 0.1 | GO:0014718 | positive regulation of satellite cell activation involved in skeletal muscle regeneration(GO:0014718) |
| 0.0 | 1.1 | GO:0034219 | carbohydrate transmembrane transport(GO:0034219) |
| 0.0 | 1.8 | GO:0006611 | protein export from nucleus(GO:0006611) |
| 0.0 | 0.7 | GO:0000132 | establishment of mitotic spindle orientation(GO:0000132) |
| 0.0 | 0.1 | GO:0052041 | suppression by virus of host apoptotic process(GO:0019050) negative regulation by symbiont of host apoptotic process(GO:0033668) modulation by virus of host apoptotic process(GO:0039526) negative regulation by symbiont of host programmed cell death(GO:0052041) negative regulation by organism of programmed cell death in other organism involved in symbiotic interaction(GO:0052490) |
| 0.0 | 0.4 | GO:0006605 | protein targeting(GO:0006605) |
| 0.0 | 0.2 | GO:0051967 | negative regulation of synaptic transmission, glutamatergic(GO:0051967) |
| 0.0 | 1.3 | GO:0030514 | negative regulation of BMP signaling pathway(GO:0030514) |
| 0.0 | 0.1 | GO:0006391 | transcription initiation from mitochondrial promoter(GO:0006391) |
| 0.0 | 0.6 | GO:0007035 | vacuolar acidification(GO:0007035) |
| 0.0 | 0.1 | GO:1903926 | signal transduction involved in intra-S DNA damage checkpoint(GO:0072428) response to bisphenol A(GO:1903925) cellular response to bisphenol A(GO:1903926) |
| 0.0 | 0.5 | GO:2000171 | negative regulation of dendrite development(GO:2000171) |
| 0.0 | 1.4 | GO:0019933 | cAMP-mediated signaling(GO:0019933) |
| 0.0 | 0.7 | GO:0050974 | detection of mechanical stimulus involved in sensory perception(GO:0050974) |
| 0.0 | 0.2 | GO:0007016 | cytoskeletal anchoring at plasma membrane(GO:0007016) |
| 0.0 | 0.5 | GO:0043162 | ubiquitin-dependent protein catabolic process via the multivesicular body sorting pathway(GO:0043162) |
| 0.0 | 0.6 | GO:0016338 | calcium-independent cell-cell adhesion via plasma membrane cell-adhesion molecules(GO:0016338) |
| 0.0 | 0.9 | GO:0050808 | synapse organization(GO:0050808) |
| 0.0 | 0.1 | GO:0021513 | spinal cord dorsal/ventral patterning(GO:0021513) |
| 0.0 | 0.8 | GO:0034314 | Arp2/3 complex-mediated actin nucleation(GO:0034314) |
| 0.0 | 1.2 | GO:0060997 | dendritic spine morphogenesis(GO:0060997) |
| 0.0 | 3.9 | GO:0050911 | detection of chemical stimulus involved in sensory perception of smell(GO:0050911) |
| 0.0 | 0.3 | GO:1901673 | regulation of mitotic spindle assembly(GO:1901673) |
| 0.0 | 0.1 | GO:0032873 | negative regulation of stress-activated MAPK cascade(GO:0032873) negative regulation of stress-activated protein kinase signaling cascade(GO:0070303) |
| 0.0 | 0.4 | GO:0070884 | regulation of calcineurin-NFAT signaling cascade(GO:0070884) |
| 0.0 | 0.2 | GO:0090160 | Golgi to lysosome transport(GO:0090160) |
| 0.0 | 0.2 | GO:0007351 | tripartite regional subdivision(GO:0007351) anterior/posterior axis specification, embryo(GO:0008595) |
| 0.0 | 0.4 | GO:0035024 | negative regulation of Rho protein signal transduction(GO:0035024) |
| 0.0 | 0.2 | GO:1901748 | leukotriene D4 metabolic process(GO:1901748) leukotriene D4 biosynthetic process(GO:1901750) |
| 0.0 | 0.3 | GO:0060548 | negative regulation of cell death(GO:0060548) |
| 0.0 | 0.1 | GO:1903487 | regulation of lactation(GO:1903487) |
| 0.0 | 0.8 | GO:0035666 | TRIF-dependent toll-like receptor signaling pathway(GO:0035666) |
| 0.0 | 0.3 | GO:0034587 | piRNA metabolic process(GO:0034587) |
| 0.0 | 0.1 | GO:0048254 | snoRNA localization(GO:0048254) |
| 0.0 | 0.2 | GO:1902043 | positive regulation of extrinsic apoptotic signaling pathway via death domain receptors(GO:1902043) |
| 0.0 | 0.3 | GO:0006750 | glutathione biosynthetic process(GO:0006750) |
| 0.0 | 0.1 | GO:0006102 | isocitrate metabolic process(GO:0006102) |
| 0.0 | 0.3 | GO:0042340 | keratan sulfate catabolic process(GO:0042340) |
| 0.0 | 0.9 | GO:1904893 | negative regulation of JAK-STAT cascade(GO:0046426) negative regulation of STAT cascade(GO:1904893) |
| 0.0 | 4.2 | GO:0007411 | axon guidance(GO:0007411) |
| 0.0 | 0.2 | GO:0016576 | histone dephosphorylation(GO:0016576) |
| 0.0 | 0.2 | GO:0006346 | methylation-dependent chromatin silencing(GO:0006346) |
| 0.0 | 0.1 | GO:0060011 | Sertoli cell proliferation(GO:0060011) |
| 0.0 | 0.8 | GO:0042733 | embryonic digit morphogenesis(GO:0042733) |
| 0.0 | 0.4 | GO:0014002 | astrocyte development(GO:0014002) |
| 0.0 | 0.4 | GO:0051260 | protein homooligomerization(GO:0051260) |
| 0.0 | 0.2 | GO:0006312 | mitotic recombination(GO:0006312) |
| 0.0 | 0.7 | GO:0030224 | monocyte differentiation(GO:0030224) |
| 0.0 | 0.6 | GO:0010862 | positive regulation of pathway-restricted SMAD protein phosphorylation(GO:0010862) |
Gene overrepresentation in cellular_component category:
| Log-likelihood per target | Total log-likelihood | Term | Description |
|---|---|---|---|
| 0.3 | 1.3 | GO:0048237 | rough endoplasmic reticulum lumen(GO:0048237) |
| 0.3 | 0.6 | GO:0033150 | cytoskeletal calyx(GO:0033150) |
| 0.3 | 0.8 | GO:0043159 | acrosomal matrix(GO:0043159) |
| 0.3 | 2.5 | GO:0070033 | synaptobrevin 2-SNAP-25-syntaxin-1a-complexin II complex(GO:0070033) synaptobrevin 2-SNAP-25-syntaxin-3-complexin complex(GO:0070554) |
| 0.2 | 2.2 | GO:0044305 | calyx of Held(GO:0044305) |
| 0.2 | 1.0 | GO:0071148 | TEAD-1-YAP complex(GO:0071148) |
| 0.2 | 2.7 | GO:0005641 | nuclear envelope lumen(GO:0005641) |
| 0.2 | 4.7 | GO:0043194 | axon initial segment(GO:0043194) |
| 0.2 | 1.7 | GO:0070852 | cell body fiber(GO:0070852) |
| 0.1 | 1.2 | GO:0044326 | dendritic spine neck(GO:0044326) |
| 0.1 | 0.4 | GO:1990742 | microvesicle(GO:1990742) |
| 0.1 | 2.2 | GO:0014701 | junctional sarcoplasmic reticulum membrane(GO:0014701) |
| 0.1 | 2.0 | GO:0033010 | paranodal junction(GO:0033010) |
| 0.1 | 0.5 | GO:0060187 | cell pole(GO:0060187) |
| 0.1 | 1.1 | GO:0005587 | collagen type IV trimer(GO:0005587) |
| 0.1 | 3.7 | GO:0031045 | dense core granule(GO:0031045) |
| 0.1 | 1.3 | GO:0098647 | collagen type VI trimer(GO:0005589) collagen beaded filament(GO:0098647) |
| 0.1 | 0.8 | GO:0000801 | central element(GO:0000801) |
| 0.1 | 0.5 | GO:0005958 | DNA-dependent protein kinase-DNA ligase 4 complex(GO:0005958) |
| 0.1 | 2.2 | GO:0005892 | acetylcholine-gated channel complex(GO:0005892) |
| 0.1 | 0.5 | GO:1990131 | Gtr1-Gtr2 GTPase complex(GO:1990131) |
| 0.1 | 0.5 | GO:0000308 | cytoplasmic cyclin-dependent protein kinase holoenzyme complex(GO:0000308) |
| 0.1 | 1.6 | GO:0001518 | voltage-gated sodium channel complex(GO:0001518) |
| 0.1 | 0.4 | GO:0000942 | condensed nuclear chromosome outer kinetochore(GO:0000942) |
| 0.1 | 3.8 | GO:0032281 | AMPA glutamate receptor complex(GO:0032281) |
| 0.1 | 0.5 | GO:0005945 | 6-phosphofructokinase complex(GO:0005945) |
| 0.1 | 1.6 | GO:0017146 | NMDA selective glutamate receptor complex(GO:0017146) |
| 0.1 | 0.4 | GO:0098536 | deuterosome(GO:0098536) |
| 0.1 | 3.6 | GO:0048786 | presynaptic active zone(GO:0048786) |
| 0.1 | 0.6 | GO:0033503 | HULC complex(GO:0033503) |
| 0.1 | 1.3 | GO:0034663 | endoplasmic reticulum chaperone complex(GO:0034663) |
| 0.1 | 0.8 | GO:0005686 | U2 snRNP(GO:0005686) |
| 0.1 | 0.8 | GO:0072546 | ER membrane protein complex(GO:0072546) |
| 0.0 | 3.8 | GO:0030964 | mitochondrial respiratory chain complex I(GO:0005747) NADH dehydrogenase complex(GO:0030964) respiratory chain complex I(GO:0045271) |
| 0.0 | 0.2 | GO:0031084 | BLOC-2 complex(GO:0031084) |
| 0.0 | 1.1 | GO:0042622 | photoreceptor outer segment membrane(GO:0042622) |
| 0.0 | 0.6 | GO:0000940 | condensed chromosome outer kinetochore(GO:0000940) |
| 0.0 | 0.3 | GO:0090661 | box H/ACA scaRNP complex(GO:0072589) box H/ACA telomerase RNP complex(GO:0090661) |
| 0.0 | 0.8 | GO:1990454 | L-type voltage-gated calcium channel complex(GO:1990454) |
| 0.0 | 2.0 | GO:0005921 | gap junction(GO:0005921) |
| 0.0 | 0.7 | GO:0001520 | outer dense fiber(GO:0001520) |
| 0.0 | 0.7 | GO:0030061 | mitochondrial crista(GO:0030061) |
| 0.0 | 0.8 | GO:0031089 | platelet dense granule lumen(GO:0031089) |
| 0.0 | 1.6 | GO:0005868 | cytoplasmic dynein complex(GO:0005868) |
| 0.0 | 1.4 | GO:0071011 | precatalytic spliceosome(GO:0071011) |
| 0.0 | 0.3 | GO:0016272 | prefoldin complex(GO:0016272) |
| 0.0 | 7.8 | GO:0043204 | perikaryon(GO:0043204) |
| 0.0 | 5.5 | GO:0005902 | microvillus(GO:0005902) |
| 0.0 | 0.9 | GO:0031254 | uropod(GO:0001931) cell trailing edge(GO:0031254) |
| 0.0 | 0.2 | GO:0009328 | phenylalanine-tRNA ligase complex(GO:0009328) |
| 0.0 | 9.3 | GO:0031225 | anchored component of membrane(GO:0031225) |
| 0.0 | 1.5 | GO:0030057 | desmosome(GO:0030057) |
| 0.0 | 0.3 | GO:0034363 | intermediate-density lipoprotein particle(GO:0034363) |
| 0.0 | 0.4 | GO:0008074 | guanylate cyclase complex, soluble(GO:0008074) |
| 0.0 | 0.2 | GO:0000221 | vacuolar proton-transporting V-type ATPase, V1 domain(GO:0000221) |
| 0.0 | 0.9 | GO:0005890 | sodium:potassium-exchanging ATPase complex(GO:0005890) |
| 0.0 | 0.3 | GO:0061574 | ASAP complex(GO:0061574) |
| 0.0 | 0.4 | GO:0070938 | contractile ring(GO:0070938) |
| 0.0 | 0.6 | GO:0001741 | XY body(GO:0001741) |
| 0.0 | 2.0 | GO:1904115 | axon cytoplasm(GO:1904115) |
| 0.0 | 1.2 | GO:0002080 | acrosomal membrane(GO:0002080) |
| 0.0 | 0.7 | GO:0045009 | melanosome membrane(GO:0033162) chitosome(GO:0045009) |
| 0.0 | 0.7 | GO:0005581 | collagen trimer(GO:0005581) |
| 0.0 | 0.2 | GO:1990037 | Lewy body core(GO:1990037) |
| 0.0 | 0.2 | GO:0031314 | extrinsic component of mitochondrial inner membrane(GO:0031314) |
| 0.0 | 0.1 | GO:0002189 | ribose phosphate diphosphokinase complex(GO:0002189) |
| 0.0 | 0.4 | GO:0033270 | paranode region of axon(GO:0033270) |
| 0.0 | 1.0 | GO:0034451 | centriolar satellite(GO:0034451) |
| 0.0 | 1.0 | GO:0030315 | T-tubule(GO:0030315) |
| 0.0 | 9.4 | GO:0045211 | postsynaptic membrane(GO:0045211) |
| 0.0 | 0.3 | GO:0044300 | cerebellar mossy fiber(GO:0044300) |
| 0.0 | 0.6 | GO:0008021 | synaptic vesicle(GO:0008021) |
| 0.0 | 4.4 | GO:0005882 | intermediate filament(GO:0005882) |
| 0.0 | 0.4 | GO:0033179 | proton-transporting V-type ATPase, V0 domain(GO:0033179) |
| 0.0 | 0.6 | GO:0005885 | Arp2/3 protein complex(GO:0005885) |
| 0.0 | 0.8 | GO:0000795 | synaptonemal complex(GO:0000795) |
| 0.0 | 0.3 | GO:0001673 | male germ cell nucleus(GO:0001673) |
| 0.0 | 0.6 | GO:0005881 | cytoplasmic microtubule(GO:0005881) |
| 0.0 | 11.2 | GO:0005578 | proteinaceous extracellular matrix(GO:0005578) |
| 0.0 | 0.2 | GO:0008024 | cyclin/CDK positive transcription elongation factor complex(GO:0008024) |
| 0.0 | 0.8 | GO:0000159 | protein phosphatase type 2A complex(GO:0000159) |
| 0.0 | 0.8 | GO:0016328 | lateral plasma membrane(GO:0016328) |
| 0.0 | 0.1 | GO:1902912 | pyruvate kinase complex(GO:1902912) |
| 0.0 | 0.1 | GO:0044530 | supraspliceosomal complex(GO:0044530) |
| 0.0 | 1.3 | GO:0005871 | kinesin complex(GO:0005871) |
| 0.0 | 0.4 | GO:0031012 | extracellular matrix(GO:0031012) |
| 0.0 | 0.3 | GO:0071004 | U2-type prespliceosome(GO:0071004) |
| 0.0 | 0.2 | GO:0031298 | replication fork protection complex(GO:0031298) |
| 0.0 | 0.1 | GO:0034751 | aryl hydrocarbon receptor complex(GO:0034751) |
| 0.0 | 1.1 | GO:0031907 | peroxisomal matrix(GO:0005782) microbody lumen(GO:0031907) |
| 0.0 | 1.7 | GO:0030864 | cortical actin cytoskeleton(GO:0030864) |
| 0.0 | 0.2 | GO:0000439 | core TFIIH complex(GO:0000439) |
| 0.0 | 0.8 | GO:0030665 | clathrin-coated vesicle membrane(GO:0030665) |
| 0.0 | 0.8 | GO:0031201 | SNARE complex(GO:0031201) |
| 0.0 | 4.0 | GO:0016323 | basolateral plasma membrane(GO:0016323) |
| 0.0 | 0.1 | GO:0034464 | BBSome(GO:0034464) |
| 0.0 | 0.1 | GO:0036057 | filtration diaphragm(GO:0036056) slit diaphragm(GO:0036057) |
| 0.0 | 0.9 | GO:0005741 | mitochondrial outer membrane(GO:0005741) |
| 0.0 | 1.3 | GO:0005905 | clathrin-coated pit(GO:0005905) |
| 0.0 | 0.0 | GO:0017109 | glutamate-cysteine ligase complex(GO:0017109) |
| 0.0 | 0.2 | GO:0097440 | apical dendrite(GO:0097440) |
| 0.0 | 0.1 | GO:0005658 | alpha DNA polymerase:primase complex(GO:0005658) |
| 0.0 | 0.8 | GO:0035580 | specific granule lumen(GO:0035580) |
| 0.0 | 0.3 | GO:0000421 | autophagosome membrane(GO:0000421) |
Gene overrepresentation in molecular_function category:
| Log-likelihood per target | Total log-likelihood | Term | Description |
|---|---|---|---|
| 0.7 | 3.5 | GO:0060961 | phospholipase D inhibitor activity(GO:0060961) |
| 0.6 | 1.9 | GO:0002113 | interleukin-33 binding(GO:0002113) |
| 0.6 | 1.7 | GO:0036393 | thiocyanate peroxidase activity(GO:0036393) |
| 0.5 | 2.5 | GO:0033265 | acetylcholinesterase activity(GO:0003990) choline binding(GO:0033265) |
| 0.5 | 1.5 | GO:0072544 | L-DOPA receptor activity(GO:0035643) L-DOPA binding(GO:0072544) |
| 0.4 | 1.8 | GO:0031694 | alpha-2A adrenergic receptor binding(GO:0031694) |
| 0.4 | 3.0 | GO:0047756 | chondroitin 4-sulfotransferase activity(GO:0047756) |
| 0.4 | 1.5 | GO:0005042 | netrin receptor activity(GO:0005042) |
| 0.4 | 3.1 | GO:0004064 | arylesterase activity(GO:0004064) |
| 0.4 | 1.1 | GO:0031877 | somatostatin receptor binding(GO:0031877) |
| 0.4 | 3.6 | GO:0008046 | axon guidance receptor activity(GO:0008046) |
| 0.3 | 2.4 | GO:0015198 | oligopeptide transporter activity(GO:0015198) |
| 0.3 | 1.9 | GO:0015265 | urea channel activity(GO:0015265) |
| 0.3 | 1.9 | GO:0008889 | glycerophosphodiester phosphodiesterase activity(GO:0008889) |
| 0.3 | 1.1 | GO:0005018 | platelet-derived growth factor alpha-receptor activity(GO:0005018) |
| 0.3 | 1.3 | GO:0031708 | endothelin B receptor binding(GO:0031708) |
| 0.3 | 3.9 | GO:0070324 | thyroid hormone binding(GO:0070324) |
| 0.2 | 1.6 | GO:0086089 | voltage-gated potassium channel activity involved in atrial cardiac muscle cell action potential repolarization(GO:0086089) |
| 0.2 | 0.9 | GO:0052810 | 1-phosphatidylinositol-5-kinase activity(GO:0052810) |
| 0.2 | 0.9 | GO:0003858 | 3-hydroxybutyrate dehydrogenase activity(GO:0003858) |
| 0.2 | 0.9 | GO:0005483 | soluble NSF attachment protein activity(GO:0005483) |
| 0.2 | 0.6 | GO:0047225 | acetylgalactosaminyl-O-glycosyl-glycoprotein beta-1,6-N-acetylglucosaminyltransferase activity(GO:0047225) |
| 0.2 | 0.6 | GO:0004818 | glutamate-tRNA ligase activity(GO:0004818) |
| 0.2 | 1.0 | GO:0008798 | beta-aspartyl-peptidase activity(GO:0008798) |
| 0.2 | 0.9 | GO:0035529 | NADH pyrophosphatase activity(GO:0035529) |
| 0.2 | 6.4 | GO:0005229 | intracellular calcium activated chloride channel activity(GO:0005229) |
| 0.2 | 1.2 | GO:0008597 | calcium-dependent protein serine/threonine phosphatase regulator activity(GO:0008597) |
| 0.2 | 1.7 | GO:0001665 | alpha-N-acetylgalactosaminide alpha-2,6-sialyltransferase activity(GO:0001665) |
| 0.2 | 2.3 | GO:0022850 | serotonin-gated cation channel activity(GO:0022850) |
| 0.2 | 4.6 | GO:0086080 | protein binding involved in heterotypic cell-cell adhesion(GO:0086080) |
| 0.2 | 0.8 | GO:0004692 | cGMP-dependent protein kinase activity(GO:0004692) |
| 0.2 | 0.6 | GO:0004040 | amidase activity(GO:0004040) |
| 0.2 | 1.1 | GO:0060230 | lipoprotein lipase activator activity(GO:0060230) |
| 0.2 | 3.4 | GO:0033038 | bitter taste receptor activity(GO:0033038) |
| 0.2 | 0.5 | GO:0052895 | norspermine:oxygen oxidoreductase activity(GO:0052894) N1-acetylspermine:oxygen oxidoreductase (N1-acetylspermidine-forming) activity(GO:0052895) |
| 0.2 | 1.7 | GO:0019237 | centromeric DNA binding(GO:0019237) |
| 0.1 | 3.1 | GO:0008179 | adenylate cyclase binding(GO:0008179) |
| 0.1 | 1.3 | GO:0008131 | primary amine oxidase activity(GO:0008131) |
| 0.1 | 7.5 | GO:0015020 | glucuronosyltransferase activity(GO:0015020) |
| 0.1 | 1.7 | GO:0043176 | amine binding(GO:0043176) serotonin binding(GO:0051378) |
| 0.1 | 0.4 | GO:0052871 | tocopherol omega-hydroxylase activity(GO:0052870) alpha-tocopherol omega-hydroxylase activity(GO:0052871) 20-hydroxy-leukotriene B4 omega oxidase activity(GO:0097258) 20-aldehyde-leukotriene B4 20-monooxygenase activity(GO:0097259) |
| 0.1 | 0.8 | GO:1990430 | extracellular matrix protein binding(GO:1990430) |
| 0.1 | 0.4 | GO:0004069 | L-aspartate:2-oxoglutarate aminotransferase activity(GO:0004069) |
| 0.1 | 1.0 | GO:0004800 | thyroxine 5'-deiodinase activity(GO:0004800) |
| 0.1 | 1.2 | GO:0015501 | glutamate:sodium symporter activity(GO:0015501) |
| 0.1 | 1.5 | GO:0030274 | LIM domain binding(GO:0030274) |
| 0.1 | 1.0 | GO:0000155 | phosphorelay sensor kinase activity(GO:0000155) |
| 0.1 | 0.7 | GO:0046556 | alpha-L-arabinofuranosidase activity(GO:0046556) |
| 0.1 | 0.4 | GO:1902122 | chenodeoxycholic acid binding(GO:1902122) |
| 0.1 | 3.7 | GO:0005104 | fibroblast growth factor receptor binding(GO:0005104) |
| 0.1 | 0.6 | GO:0043515 | kinetochore binding(GO:0043515) |
| 0.1 | 1.9 | GO:0015279 | store-operated calcium channel activity(GO:0015279) |
| 0.1 | 0.5 | GO:0005219 | ryanodine-sensitive calcium-release channel activity(GO:0005219) |
| 0.1 | 0.8 | GO:0086056 | voltage-gated calcium channel activity involved in AV node cell action potential(GO:0086056) |
| 0.1 | 0.3 | GO:0050571 | 1,5-anhydro-D-fructose reductase activity(GO:0050571) |
| 0.1 | 0.7 | GO:0005223 | intracellular cGMP activated cation channel activity(GO:0005223) |
| 0.1 | 0.8 | GO:0031752 | D5 dopamine receptor binding(GO:0031752) |
| 0.1 | 0.7 | GO:0003987 | acetate-CoA ligase activity(GO:0003987) |
| 0.1 | 1.1 | GO:0005372 | water transmembrane transporter activity(GO:0005372) |
| 0.1 | 0.7 | GO:0016907 | G-protein coupled acetylcholine receptor activity(GO:0016907) |
| 0.1 | 0.3 | GO:0047977 | hepoxilin-epoxide hydrolase activity(GO:0047977) |
| 0.1 | 1.6 | GO:0019864 | IgG binding(GO:0019864) |
| 0.1 | 4.7 | GO:0004364 | glutathione transferase activity(GO:0004364) |
| 0.1 | 1.0 | GO:0050694 | galactosylceramide sulfotransferase activity(GO:0001733) galactose 3-O-sulfotransferase activity(GO:0050694) |
| 0.1 | 0.4 | GO:0031727 | CCR2 chemokine receptor binding(GO:0031727) |
| 0.1 | 1.4 | GO:0004971 | AMPA glutamate receptor activity(GO:0004971) |
| 0.1 | 1.3 | GO:0003796 | lysozyme activity(GO:0003796) |
| 0.1 | 0.9 | GO:0004332 | fructose-bisphosphate aldolase activity(GO:0004332) |
| 0.1 | 0.5 | GO:0005502 | 11-cis retinal binding(GO:0005502) |
| 0.1 | 3.7 | GO:0042056 | chemoattractant activity(GO:0042056) |
| 0.1 | 2.0 | GO:0004062 | aryl sulfotransferase activity(GO:0004062) |
| 0.1 | 1.6 | GO:0045504 | dynein heavy chain binding(GO:0045504) |
| 0.1 | 1.0 | GO:0004128 | cytochrome-b5 reductase activity, acting on NAD(P)H(GO:0004128) |
| 0.1 | 0.2 | GO:0003880 | protein C-terminal carboxyl O-methyltransferase activity(GO:0003880) |
| 0.1 | 0.9 | GO:0008430 | selenium binding(GO:0008430) |
| 0.1 | 1.3 | GO:0005432 | calcium:sodium antiporter activity(GO:0005432) |
| 0.1 | 0.3 | GO:1990404 | protein ADP-ribosylase activity(GO:1990404) |
| 0.1 | 0.5 | GO:0001594 | trace-amine receptor activity(GO:0001594) |
| 0.1 | 2.2 | GO:0019992 | diacylglycerol binding(GO:0019992) |
| 0.1 | 0.4 | GO:0098519 | nucleotide phosphatase activity, acting on free nucleotides(GO:0098519) |
| 0.1 | 2.0 | GO:0002162 | dystroglycan binding(GO:0002162) |
| 0.1 | 0.2 | GO:0016855 | racemase and epimerase activity, acting on amino acids and derivatives(GO:0016855) racemase activity, acting on amino acids and derivatives(GO:0036361) amino-acid racemase activity(GO:0047661) |
| 0.1 | 0.4 | GO:0080019 | fatty-acyl-CoA reductase (alcohol-forming) activity(GO:0080019) |
| 0.1 | 1.4 | GO:0004143 | diacylglycerol kinase activity(GO:0004143) |
| 0.1 | 0.5 | GO:0008172 | S-methyltransferase activity(GO:0008172) |
| 0.1 | 0.8 | GO:0008503 | benzodiazepine receptor activity(GO:0008503) |
| 0.1 | 0.4 | GO:0043295 | glutathione binding(GO:0043295) |
| 0.1 | 0.5 | GO:0003872 | 6-phosphofructokinase activity(GO:0003872) |
| 0.1 | 1.1 | GO:0015271 | outward rectifier potassium channel activity(GO:0015271) |
| 0.1 | 0.9 | GO:0030548 | acetylcholine receptor regulator activity(GO:0030548) neurotransmitter receptor regulator activity(GO:0099602) |
| 0.1 | 1.7 | GO:0047555 | 3',5'-cyclic-GMP phosphodiesterase activity(GO:0047555) |
| 0.1 | 1.9 | GO:0016702 | oxidoreductase activity, acting on single donors with incorporation of molecular oxygen, incorporation of two atoms of oxygen(GO:0016702) |
| 0.1 | 0.3 | GO:0035402 | histone kinase activity (H3-T11 specific)(GO:0035402) |
| 0.1 | 0.3 | GO:0032217 | riboflavin transporter activity(GO:0032217) |
| 0.1 | 4.5 | GO:0050840 | extracellular matrix binding(GO:0050840) |
| 0.0 | 0.2 | GO:0061628 | H3K27me3 modified histone binding(GO:0061628) |
| 0.0 | 0.7 | GO:0038062 | protein tyrosine kinase collagen receptor activity(GO:0038062) |
| 0.0 | 0.6 | GO:0019784 | NEDD8-specific protease activity(GO:0019784) |
| 0.0 | 0.2 | GO:0102008 | cytosolic dipeptidase activity(GO:0102008) |
| 0.0 | 0.2 | GO:0052829 | inositol-1,4-bisphosphate 1-phosphatase activity(GO:0004441) inositol-1,3,4-trisphosphate 1-phosphatase activity(GO:0052829) |
| 0.0 | 0.7 | GO:0005132 | type I interferon receptor binding(GO:0005132) |
| 0.0 | 0.7 | GO:0017034 | Rap guanyl-nucleotide exchange factor activity(GO:0017034) |
| 0.0 | 3.1 | GO:0001786 | phosphatidylserine binding(GO:0001786) |
| 0.0 | 1.0 | GO:0019841 | retinol binding(GO:0019841) |
| 0.0 | 1.9 | GO:0004653 | polypeptide N-acetylgalactosaminyltransferase activity(GO:0004653) |
| 0.0 | 0.1 | GO:0004821 | histidine-tRNA ligase activity(GO:0004821) |
| 0.0 | 2.2 | GO:0017075 | syntaxin-1 binding(GO:0017075) |
| 0.0 | 0.4 | GO:0016167 | glial cell-derived neurotrophic factor receptor activity(GO:0016167) |
| 0.0 | 0.3 | GO:0004127 | cytidylate kinase activity(GO:0004127) |
| 0.0 | 0.8 | GO:0015467 | G-protein activated inward rectifier potassium channel activity(GO:0015467) |
| 0.0 | 1.7 | GO:0005545 | 1-phosphatidylinositol binding(GO:0005545) |
| 0.0 | 0.5 | GO:0016724 | ferroxidase activity(GO:0004322) oxidoreductase activity, oxidizing metal ions, oxygen as acceptor(GO:0016724) |
| 0.0 | 0.4 | GO:1904929 | coreceptor activity involved in Wnt signaling pathway, planar cell polarity pathway(GO:1904929) |
| 0.0 | 0.2 | GO:0004974 | leukotriene receptor activity(GO:0004974) |
| 0.0 | 1.2 | GO:0004890 | GABA-A receptor activity(GO:0004890) |
| 0.0 | 0.7 | GO:0003707 | steroid hormone receptor activity(GO:0003707) |
| 0.0 | 1.9 | GO:0004198 | calcium-dependent cysteine-type endopeptidase activity(GO:0004198) |
| 0.0 | 0.2 | GO:0031726 | CCR1 chemokine receptor binding(GO:0031726) |
| 0.0 | 0.2 | GO:0016499 | orexin receptor activity(GO:0016499) |
| 0.0 | 0.4 | GO:0034235 | GPI anchor binding(GO:0034235) |
| 0.0 | 0.7 | GO:0022833 | mechanically-gated ion channel activity(GO:0008381) mechanically gated channel activity(GO:0022833) |
| 0.0 | 0.1 | GO:0008969 | phosphohistidine phosphatase activity(GO:0008969) |
| 0.0 | 0.2 | GO:0015616 | DNA translocase activity(GO:0015616) |
| 0.0 | 0.3 | GO:0001849 | complement component C1q binding(GO:0001849) |
| 0.0 | 0.3 | GO:0050733 | RS domain binding(GO:0050733) |
| 0.0 | 0.9 | GO:0005391 | sodium:potassium-exchanging ATPase activity(GO:0005391) |
| 0.0 | 0.5 | GO:0001758 | retinal dehydrogenase activity(GO:0001758) |
| 0.0 | 0.2 | GO:0004775 | succinate-CoA ligase (ADP-forming) activity(GO:0004775) |
| 0.0 | 1.5 | GO:0071855 | neuropeptide receptor binding(GO:0071855) |
| 0.0 | 1.6 | GO:0005549 | odorant binding(GO:0005549) |
| 0.0 | 1.1 | GO:1905030 | voltage-gated sodium channel activity(GO:0005248) voltage-gated ion channel activity involved in regulation of postsynaptic membrane potential(GO:1905030) |
| 0.0 | 0.8 | GO:0042043 | neurexin family protein binding(GO:0042043) |
| 0.0 | 0.1 | GO:0005010 | insulin-like growth factor-activated receptor activity(GO:0005010) |
| 0.0 | 0.3 | GO:0034513 | box H/ACA snoRNA binding(GO:0034513) |
| 0.0 | 0.5 | GO:0015386 | potassium:proton antiporter activity(GO:0015386) |
| 0.0 | 0.3 | GO:0099589 | serotonin receptor activity(GO:0099589) |
| 0.0 | 0.1 | GO:0002134 | pyrimidine nucleoside binding(GO:0001884) UTP binding(GO:0002134) sulfonylurea receptor binding(GO:0017098) pyrimidine ribonucleoside binding(GO:0032551) |
| 0.0 | 0.3 | GO:0030620 | U2 snRNA binding(GO:0030620) |
| 0.0 | 1.3 | GO:0008157 | protein phosphatase 1 binding(GO:0008157) |
| 0.0 | 0.2 | GO:0016802 | adenosylhomocysteinase activity(GO:0004013) trialkylsulfonium hydrolase activity(GO:0016802) |
| 0.0 | 0.8 | GO:0008191 | metalloendopeptidase inhibitor activity(GO:0008191) |
| 0.0 | 0.6 | GO:0008432 | JUN kinase binding(GO:0008432) |
| 0.0 | 1.5 | GO:0005154 | epidermal growth factor receptor binding(GO:0005154) |
| 0.0 | 0.4 | GO:0017128 | phospholipid scramblase activity(GO:0017128) |
| 0.0 | 2.8 | GO:0004714 | transmembrane receptor protein tyrosine kinase activity(GO:0004714) |
| 0.0 | 0.4 | GO:0001162 | RNA polymerase II intronic transcription regulatory region sequence-specific DNA binding(GO:0001162) |
| 0.0 | 0.1 | GO:1990698 | palmitoleoyltransferase activity(GO:1990698) |
| 0.0 | 6.4 | GO:0005200 | structural constituent of cytoskeleton(GO:0005200) |
| 0.0 | 0.2 | GO:0004826 | phenylalanine-tRNA ligase activity(GO:0004826) |
| 0.0 | 0.4 | GO:0010314 | phosphatidylinositol-5-phosphate binding(GO:0010314) |
| 0.0 | 0.3 | GO:0051425 | PTB domain binding(GO:0051425) |
| 0.0 | 0.2 | GO:0070273 | phosphatidylinositol-4-phosphate binding(GO:0070273) |
| 0.0 | 0.3 | GO:0052650 | NADP-retinol dehydrogenase activity(GO:0052650) |
| 0.0 | 1.1 | GO:0005245 | voltage-gated calcium channel activity(GO:0005245) |
| 0.0 | 0.5 | GO:0015245 | fatty acid transporter activity(GO:0015245) |
| 0.0 | 1.3 | GO:0061631 | ubiquitin conjugating enzyme activity(GO:0061631) |
| 0.0 | 0.6 | GO:0031435 | mitogen-activated protein kinase kinase kinase binding(GO:0031435) |
| 0.0 | 1.5 | GO:0005198 | structural molecule activity(GO:0005198) |
| 0.0 | 0.1 | GO:0070699 | type II activin receptor binding(GO:0070699) |
| 0.0 | 0.6 | GO:0001968 | fibronectin binding(GO:0001968) |
| 0.0 | 0.1 | GO:0004449 | isocitrate dehydrogenase (NAD+) activity(GO:0004449) |
| 0.0 | 0.2 | GO:0008559 | xenobiotic-transporting ATPase activity(GO:0008559) |
| 0.0 | 1.2 | GO:0005310 | dicarboxylic acid transmembrane transporter activity(GO:0005310) |
| 0.0 | 0.7 | GO:0000062 | fatty-acyl-CoA binding(GO:0000062) |
| 0.0 | 0.1 | GO:0052656 | branched-chain-amino-acid transaminase activity(GO:0004084) L-leucine transaminase activity(GO:0052654) L-valine transaminase activity(GO:0052655) L-isoleucine transaminase activity(GO:0052656) |
| 0.0 | 0.5 | GO:0001134 | transcription factor activity, transcription factor recruiting(GO:0001134) |
| 0.0 | 0.6 | GO:0051537 | 2 iron, 2 sulfur cluster binding(GO:0051537) |
| 0.0 | 0.3 | GO:0031489 | myosin V binding(GO:0031489) |
| 0.0 | 0.1 | GO:0043120 | tumor necrosis factor binding(GO:0043120) |
| 0.0 | 0.4 | GO:0008574 | ATP-dependent microtubule motor activity, plus-end-directed(GO:0008574) |
| 0.0 | 0.5 | GO:0017127 | cholesterol transporter activity(GO:0017127) |
| 0.0 | 0.1 | GO:0070990 | snRNP binding(GO:0070990) |
| 0.0 | 0.1 | GO:0000179 | rRNA (adenine-N6,N6-)-dimethyltransferase activity(GO:0000179) |
| 0.0 | 0.6 | GO:0046961 | proton-transporting ATPase activity, rotational mechanism(GO:0046961) |
| 0.0 | 0.3 | GO:0070513 | death domain binding(GO:0070513) |
| 0.0 | 0.3 | GO:0055056 | D-glucose transmembrane transporter activity(GO:0055056) |
| 0.0 | 0.8 | GO:1901476 | carbohydrate transmembrane transporter activity(GO:0015144) carbohydrate transporter activity(GO:1901476) |
| 0.0 | 0.2 | GO:0001591 | dopamine neurotransmitter receptor activity, coupled via Gi/Go(GO:0001591) |
| 0.0 | 4.3 | GO:0016810 | hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds(GO:0016810) |
| 0.0 | 0.8 | GO:0042169 | SH2 domain binding(GO:0042169) |
| 0.0 | 0.1 | GO:0047006 | 17-alpha,20-alpha-dihydroxypregn-4-en-3-one dehydrogenase activity(GO:0047006) |
| 0.0 | 3.3 | GO:0017137 | Rab GTPase binding(GO:0017137) |
| 0.0 | 0.5 | GO:0030552 | cAMP binding(GO:0030552) |
| 0.0 | 0.2 | GO:0036374 | glutathione hydrolase activity(GO:0036374) |
| 0.0 | 0.3 | GO:0004065 | arylsulfatase activity(GO:0004065) |
| 0.0 | 0.3 | GO:0045295 | gamma-catenin binding(GO:0045295) |
| 0.0 | 0.2 | GO:0005436 | sodium:phosphate symporter activity(GO:0005436) |
| 0.0 | 0.2 | GO:0097016 | L27 domain binding(GO:0097016) |
| 0.0 | 0.5 | GO:0070064 | proline-rich region binding(GO:0070064) |
| 0.0 | 1.3 | GO:0005201 | extracellular matrix structural constituent(GO:0005201) |
| 0.0 | 13.1 | GO:0005509 | calcium ion binding(GO:0005509) |
| 0.0 | 0.1 | GO:0001103 | RNA polymerase II repressing transcription factor binding(GO:0001103) |
| 0.0 | 0.5 | GO:0004623 | phospholipase A2 activity(GO:0004623) |
| 0.0 | 0.3 | GO:0017049 | GTP-Rho binding(GO:0017049) |
| 0.0 | 0.1 | GO:0004749 | ribose phosphate diphosphokinase activity(GO:0004749) |
| 0.0 | 0.2 | GO:0031005 | filamin binding(GO:0031005) |
| 0.0 | 0.1 | GO:0019869 | chloride channel inhibitor activity(GO:0019869) |
| 0.0 | 0.1 | GO:0005087 | Ran guanyl-nucleotide exchange factor activity(GO:0005087) |
| 0.0 | 0.2 | GO:0000182 | rDNA binding(GO:0000182) |
| 0.0 | 0.2 | GO:0016421 | CoA carboxylase activity(GO:0016421) |
| 0.0 | 0.4 | GO:0005031 | tumor necrosis factor-activated receptor activity(GO:0005031) death receptor activity(GO:0005035) |
| 0.0 | 0.0 | GO:0004357 | glutamate-cysteine ligase activity(GO:0004357) |
| 0.0 | 0.2 | GO:0017017 | MAP kinase tyrosine/serine/threonine phosphatase activity(GO:0017017) |
| 0.0 | 0.2 | GO:0043522 | leucine zipper domain binding(GO:0043522) |
Gene overrepresentation in curated gene sets: canonical pathways category:
| Log-likelihood per target | Total log-likelihood | Term | Description |
|---|---|---|---|
| 0.1 | 6.6 | PID ALPHA SYNUCLEIN PATHWAY | Alpha-synuclein signaling |
| 0.1 | 1.1 | PID PDGFRA PATHWAY | PDGFR-alpha signaling pathway |
| 0.0 | 3.5 | NABA PROTEOGLYCANS | Genes encoding proteoglycans |
| 0.0 | 0.7 | SA TRKA RECEPTOR | The TrkA receptor binds nerve growth factor to activate MAP kinase pathways and promote cell growth. |
| 0.0 | 0.8 | PID S1P S1P4 PATHWAY | S1P4 pathway |
| 0.0 | 1.5 | PID EPHA FWDPATHWAY | EPHA forward signaling |
| 0.0 | 1.8 | PID PI3K PLC TRK PATHWAY | Trk receptor signaling mediated by PI3K and PLC-gamma |
| 0.0 | 1.5 | ST MYOCYTE AD PATHWAY | Myocyte Adrenergic Pathway is a specific case of the generalized Adrenergic Pathway. |
| 0.0 | 3.4 | PID FGF PATHWAY | FGF signaling pathway |
| 0.0 | 0.1 | ST PAC1 RECEPTOR PATHWAY | PAC1 Receptor Pathway |
| 0.0 | 1.6 | PID ECADHERIN NASCENT AJ PATHWAY | E-cadherin signaling in the nascent adherens junction |
| 0.0 | 0.9 | PID WNT CANONICAL PATHWAY | Canonical Wnt signaling pathway |
| 0.0 | 2.4 | PID AURORA B PATHWAY | Aurora B signaling |
| 0.0 | 2.1 | PID NETRIN PATHWAY | Netrin-mediated signaling events |
| 0.0 | 2.3 | PID HNF3B PATHWAY | FOXA2 and FOXA3 transcription factor networks |
| 0.0 | 0.4 | PID ECADHERIN KERATINOCYTE PATHWAY | E-cadherin signaling in keratinocytes |
| 0.0 | 0.8 | PID HEDGEHOG 2PATHWAY | Signaling events mediated by the Hedgehog family |
| 0.0 | 1.3 | PID NFKAPPAB CANONICAL PATHWAY | Canonical NF-kappaB pathway |
| 0.0 | 1.2 | PID TCR CALCIUM PATHWAY | Calcium signaling in the CD4+ TCR pathway |
| 0.0 | 1.3 | PID ANGIOPOIETIN RECEPTOR PATHWAY | Angiopoietin receptor Tie2-mediated signaling |
| 0.0 | 2.7 | PID RHOA REG PATHWAY | Regulation of RhoA activity |
| 0.0 | 1.3 | PID AJDISS 2PATHWAY | Posttranslational regulation of adherens junction stability and dissassembly |
| 0.0 | 1.1 | PID INTEGRIN A4B1 PATHWAY | Alpha4 beta1 integrin signaling events |
| 0.0 | 0.8 | PID TXA2PATHWAY | Thromboxane A2 receptor signaling |
| 0.0 | 1.2 | PID TRKR PATHWAY | Neurotrophic factor-mediated Trk receptor signaling |
| 0.0 | 1.2 | NABA COLLAGENS | Genes encoding collagen proteins |
| 0.0 | 0.5 | PID ERBB4 PATHWAY | ErbB4 signaling events |
| 0.0 | 0.6 | PID AMB2 NEUTROPHILS PATHWAY | amb2 Integrin signaling |
| 0.0 | 0.4 | PID ERB GENOMIC PATHWAY | Validated nuclear estrogen receptor beta network |
| 0.0 | 0.3 | PID DNA PK PATHWAY | DNA-PK pathway in nonhomologous end joining |
| 0.0 | 0.5 | PID INTEGRIN CS PATHWAY | Integrin family cell surface interactions |
| 0.0 | 0.7 | PID KIT PATHWAY | Signaling events mediated by Stem cell factor receptor (c-Kit) |
| 0.0 | 0.2 | SA G2 AND M PHASES | Cdc25 activates the cdc2/cyclin B complex to induce the G2/M transition. |
Gene overrepresentation in curated gene sets: REACTOME pathways category:
| Log-likelihood per target | Total log-likelihood | Term | Description |
|---|---|---|---|
| 0.2 | 3.7 | REACTOME SIGNALING BY FGFR3 MUTANTS | Genes involved in Signaling by FGFR3 mutants |
| 0.2 | 3.4 | REACTOME ROLE OF SECOND MESSENGERS IN NETRIN1 SIGNALING | Genes involved in Role of second messengers in netrin-1 signaling |
| 0.2 | 3.1 | REACTOME REVERSIBLE HYDRATION OF CARBON DIOXIDE | Genes involved in Reversible Hydration of Carbon Dioxide |
| 0.2 | 5.1 | REACTOME GLUCURONIDATION | Genes involved in Glucuronidation |
| 0.2 | 3.6 | REACTOME NOREPINEPHRINE NEUROTRANSMITTER RELEASE CYCLE | Genes involved in Norepinephrine Neurotransmitter Release Cycle |
| 0.2 | 2.1 | REACTOME CREATION OF C4 AND C2 ACTIVATORS | Genes involved in Creation of C4 and C2 activators |
| 0.1 | 2.2 | REACTOME PRESYNAPTIC NICOTINIC ACETYLCHOLINE RECEPTORS | Genes involved in Presynaptic nicotinic acetylcholine receptors |
| 0.1 | 4.6 | REACTOME CRMPS IN SEMA3A SIGNALING | Genes involved in CRMPs in Sema3A signaling |
| 0.1 | 5.9 | REACTOME INTERACTION BETWEEN L1 AND ANKYRINS | Genes involved in Interaction between L1 and Ankyrins |
| 0.1 | 1.7 | REACTOME SEROTONIN RECEPTORS | Genes involved in Serotonin receptors |
| 0.1 | 4.1 | REACTOME CHONDROITIN SULFATE BIOSYNTHESIS | Genes involved in Chondroitin sulfate biosynthesis |
| 0.1 | 4.4 | REACTOME GLUTATHIONE CONJUGATION | Genes involved in Glutathione conjugation |
| 0.1 | 3.4 | REACTOME BETA DEFENSINS | Genes involved in Beta defensins |
| 0.1 | 1.1 | REACTOME PASSIVE TRANSPORT BY AQUAPORINS | Genes involved in Passive Transport by Aquaporins |
| 0.1 | 2.9 | REACTOME TIE2 SIGNALING | Genes involved in Tie2 Signaling |
| 0.1 | 1.5 | REACTOME APOPTOTIC CLEAVAGE OF CELL ADHESION PROTEINS | Genes involved in Apoptotic cleavage of cell adhesion proteins |
| 0.1 | 2.5 | REACTOME CGMP EFFECTS | Genes involved in cGMP effects |
| 0.1 | 5.2 | REACTOME AMYLOIDS | Genes involved in Amyloids |
| 0.0 | 1.3 | REACTOME METABOLISM OF POLYAMINES | Genes involved in Metabolism of polyamines |
| 0.0 | 1.1 | REACTOME SYNTHESIS SECRETION AND DEACYLATION OF GHRELIN | Genes involved in Synthesis, Secretion, and Deacylation of Ghrelin |
| 0.0 | 0.7 | REACTOME NEGATIVE REGULATION OF THE PI3K AKT NETWORK | Genes involved in Negative regulation of the PI3K/AKT network |
| 0.0 | 1.1 | REACTOME CTNNB1 PHOSPHORYLATION CASCADE | Genes involved in Beta-catenin phosphorylation cascade |
| 0.0 | 1.4 | REACTOME EFFECTS OF PIP2 HYDROLYSIS | Genes involved in Effects of PIP2 hydrolysis |
| 0.0 | 1.8 | REACTOME KINESINS | Genes involved in Kinesins |
| 0.0 | 1.6 | REACTOME AMINE COMPOUND SLC TRANSPORTERS | Genes involved in Amine compound SLC transporters |
| 0.0 | 0.5 | REACTOME OPSINS | Genes involved in Opsins |
| 0.0 | 2.5 | REACTOME INTEGRIN ALPHAIIB BETA3 SIGNALING | Genes involved in Integrin alphaIIb beta3 signaling |
| 0.0 | 1.6 | REACTOME INHIBITION OF VOLTAGE GATED CA2 CHANNELS VIA GBETA GAMMA SUBUNITS | Genes involved in Inhibition of voltage gated Ca2+ channels via Gbeta/gamma subunits |
| 0.0 | 1.0 | REACTOME REGULATION OF AMPK ACTIVITY VIA LKB1 | Genes involved in Regulation of AMPK activity via LKB1 |
| 0.0 | 2.1 | REACTOME VOLTAGE GATED POTASSIUM CHANNELS | Genes involved in Voltage gated Potassium channels |
| 0.0 | 1.0 | REACTOME CYTOSOLIC SULFONATION OF SMALL MOLECULES | Genes involved in Cytosolic sulfonation of small molecules |
| 0.0 | 1.4 | REACTOME TRAFFICKING OF GLUR2 CONTAINING AMPA RECEPTORS | Genes involved in Trafficking of GluR2-containing AMPA receptors |
| 0.0 | 0.8 | REACTOME INHIBITION OF INSULIN SECRETION BY ADRENALINE NORADRENALINE | Genes involved in Inhibition of Insulin Secretion by Adrenaline/Noradrenaline |
| 0.0 | 0.8 | REACTOME THROMBIN SIGNALLING THROUGH PROTEINASE ACTIVATED RECEPTORS PARS | Genes involved in Thrombin signalling through proteinase activated receptors (PARs) |
| 0.0 | 1.1 | REACTOME TRAFFICKING OF AMPA RECEPTORS | Genes involved in Trafficking of AMPA receptors |
| 0.0 | 0.9 | REACTOME REGULATION OF COMPLEMENT CASCADE | Genes involved in Regulation of Complement cascade |
| 0.0 | 1.4 | REACTOME YAP1 AND WWTR1 TAZ STIMULATED GENE EXPRESSION | Genes involved in YAP1- and WWTR1 (TAZ)-stimulated gene expression |
| 0.0 | 0.8 | REACTOME ACTIVATION OF RAC | Genes involved in Activation of Rac |
| 0.0 | 0.8 | REACTOME PLATELET CALCIUM HOMEOSTASIS | Genes involved in Platelet calcium homeostasis |
| 0.0 | 1.0 | REACTOME CHOLESTEROL BIOSYNTHESIS | Genes involved in Cholesterol biosynthesis |
| 0.0 | 1.1 | REACTOME SIGNALING BY ROBO RECEPTOR | Genes involved in Signaling by Robo receptor |
| 0.0 | 0.7 | REACTOME BRANCHED CHAIN AMINO ACID CATABOLISM | Genes involved in Branched-chain amino acid catabolism |
| 0.0 | 1.1 | REACTOME OXYGEN DEPENDENT PROLINE HYDROXYLATION OF HYPOXIA INDUCIBLE FACTOR ALPHA | Genes involved in Oxygen-dependent Proline Hydroxylation of Hypoxia-inducible Factor Alpha |
| 0.0 | 2.4 | REACTOME O LINKED GLYCOSYLATION OF MUCINS | Genes involved in O-linked glycosylation of mucins |
| 0.0 | 0.8 | REACTOME GABA A RECEPTOR ACTIVATION | Genes involved in GABA A receptor activation |
| 0.0 | 0.4 | REACTOME NITRIC OXIDE STIMULATES GUANYLATE CYCLASE | Genes involved in Nitric oxide stimulates guanylate cyclase |
| 0.0 | 0.8 | REACTOME SIGNALING BY NODAL | Genes involved in Signaling by NODAL |
| 0.0 | 1.9 | REACTOME AMINO ACID AND OLIGOPEPTIDE SLC TRANSPORTERS | Genes involved in Amino acid and oligopeptide SLC transporters |
| 0.0 | 1.1 | REACTOME ADHERENS JUNCTIONS INTERACTIONS | Genes involved in Adherens junctions interactions |
| 0.0 | 0.9 | REACTOME SYNTHESIS OF PIPS AT THE PLASMA MEMBRANE | Genes involved in Synthesis of PIPs at the plasma membrane |
| 0.0 | 0.3 | REACTOME KERATAN SULFATE DEGRADATION | Genes involved in Keratan sulfate degradation |
| 0.0 | 1.2 | REACTOME GLYCOSPHINGOLIPID METABOLISM | Genes involved in Glycosphingolipid metabolism |
| 0.0 | 0.5 | REACTOME REGULATION OF IFNA SIGNALING | Genes involved in Regulation of IFNA signaling |
| 0.0 | 0.4 | REACTOME G2 M DNA DAMAGE CHECKPOINT | Genes involved in G2/M DNA damage checkpoint |
| 0.0 | 1.3 | REACTOME COLLAGEN FORMATION | Genes involved in Collagen formation |
| 0.0 | 0.7 | REACTOME ION TRANSPORT BY P TYPE ATPASES | Genes involved in Ion transport by P-type ATPases |
| 0.0 | 1.1 | REACTOME NUCLEAR SIGNALING BY ERBB4 | Genes involved in Nuclear signaling by ERBB4 |
| 0.0 | 2.9 | REACTOME OLFACTORY SIGNALING PATHWAY | Genes involved in Olfactory Signaling Pathway |
| 0.0 | 0.3 | REACTOME FACILITATIVE NA INDEPENDENT GLUCOSE TRANSPORTERS | Genes involved in Facilitative Na+-independent glucose transporters |
| 0.0 | 0.2 | REACTOME ACTIVATION OF CHAPERONE GENES BY ATF6 ALPHA | Genes involved in Activation of Chaperone Genes by ATF6-alpha |
| 0.0 | 0.2 | REACTOME EICOSANOID LIGAND BINDING RECEPTORS | Genes involved in Eicosanoid ligand-binding receptors |
| 0.0 | 0.7 | REACTOME IRON UPTAKE AND TRANSPORT | Genes involved in Iron uptake and transport |
| 0.0 | 0.3 | REACTOME DOWNREGULATION OF SMAD2 3 SMAD4 TRANSCRIPTIONAL ACTIVITY | Genes involved in Downregulation of SMAD2/3:SMAD4 transcriptional activity |
| 0.0 | 0.6 | REACTOME GLYCOLYSIS | Genes involved in Glycolysis |